Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

RGD DISEASE ONTOLOGY - ANNOTATIONS

RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.

Term:Drug-Related Side Effects and Adverse Reactions
go back to main search page
Accession:DOID:9006810 term browser browse the term
Definition:Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.
Synonyms:exact_synonym: Adverse Drug Reaction;   Adverse Drug Reactions;   Drug Side Effect;   Drug Side Effects;   Drug Toxicities;   adverse drug event;   adverse drug events;   drug toxicity;   side effects of drugs
 narrow_synonym: antidepressant-induced dizziness
 related_synonym: Brain pseudoatrophy, reversible, valproate-induced, susceptibility to
 primary_id: MESH:D064420
 xref: EFO:0006321;   EFO:0020003


GViewer not supported for the selected species.

show annotations for term's descendants           Sort by:
Drug-Related Side Effects and Adverse Reactions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18381794 PMID:20563569 PMID:21064136 PMID:24502637 PMID:25007187 More... NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:18256692 NCBI chr 5:14,972,589...15,164,594
Ensembl chr 5:14,972,646...15,164,567
JBrowse link
G ABCC12 ATP binding cassette subfamily C member 12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 5:33,883,283...33,946,742
Ensembl chr 5:33,883,290...33,945,808
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 PMID:23222202 PMID:25007187 PMID:32387182 NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
JBrowse link
G ABCC4 ATP binding cassette subfamily C member 4 (PEL blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:23222202 NCBI chr 3:73,821,887...74,106,617
Ensembl chr 3:73,821,134...74,106,579
JBrowse link
G ABCG2 ATP binding cassette subfamily G member 2 (JR blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 PMID:32387182 NCBI chr 7:36,458,110...36,599,753 JBrowse link
G ACHE acetylcholinesterase (Cartwright blood group) ISO CTD Direct Evidence: therapeutic CTD PMID:27083141 NCBI chr28:12,328,304...12,335,302
Ensembl chr28:12,331,039...12,335,076
JBrowse link
G ADORA1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr25:26,180,898...26,221,424
Ensembl chr25:26,182,446...26,220,776
JBrowse link
G ADORA2A adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:15641640 NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
JBrowse link
G AFM afamin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 7:21,950,222...21,972,612
Ensembl chr 7:21,950,705...21,972,739
JBrowse link
G AHSG alpha 2-HS glycoprotein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr15:2,809,234...2,818,382
Ensembl chr15:2,809,028...2,817,514
JBrowse link
G ALB albumin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr12:25,508,516...25,526,821
Ensembl chr12:25,508,682...25,527,016
JBrowse link
G APOB apolipoprotein B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31186542 NCBI chr14:86,624,209...86,669,175
Ensembl chr14:86,624,332...86,668,704
JBrowse link
G ARID5B AT-rich interaction domain 5B ISO CTD Direct Evidence: marker/mechanism CTD PMID:24712521 NCBI chr 9:69,190,100...69,382,448
Ensembl chr 9:69,190,045...69,382,069
JBrowse link
G ASS1 argininosuccinate synthase 1 ISO protein:increased expression:plasma (rat) RGD PMID:20544730 RGD:4140449 NCBI chr12:7,643,484...7,701,334 JBrowse link
G ATIC 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16947783 NCBI chr10:101,128,583...101,166,668 JBrowse link
G B2M beta-2-microglobulin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr26:38,331,818...38,338,785
Ensembl chr26:38,331,442...38,338,809
JBrowse link
G BCHE butyrylcholinesterase ISO CTD Direct Evidence: marker/mechanism CTD PMID:3111302 NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
JBrowse link
G C3 complement C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 6:6,250,422...6,289,264 JBrowse link
G CACNA1H calcium voltage-gated channel subunit alpha1 H ISO CTD Direct Evidence: marker/mechanism CTD PMID:30552955 NCBI chr 5:1,039,709...1,106,212
Ensembl chr 5:1,078,973...1,106,507
JBrowse link
G CAMK2N1 calcium/calmodulin dependent protein kinase II inhibitor 1 ISO associated with colon cancer RGD PMID:22020760 RGD:15097511 NCBI chr20:112,064,718...112,068,505
Ensembl chr20:112,065,581...112,067,256
JBrowse link
G CCL2 C-C motif chemokine ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
JBrowse link
G CDA cytidine deaminase ISO DNA:SNP:cds:rs1048977|rs12726436|rs2072671 (human) RGD PMID:28347776 RGD:152995291 NCBI chr20:111,931,365...111,960,172
Ensembl chr20:111,931,364...111,960,036
JBrowse link
G CLU clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:24361871 PMID:28885000 NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
JBrowse link
G COMMD1 copper metabolism domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23583003 NCBI chr14:44,839,460...45,068,764
Ensembl chr14:44,839,542...45,068,586
JBrowse link
G CSF2 colony stimulating factor 2 ISO CTD Direct Evidence: therapeutic CTD PMID:7960606 NCBI chr23:34,906,987...34,911,252
Ensembl chr23:34,908,911...34,911,140
JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:7692001 PMID:27737899 PMID:31557154 NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
JBrowse link
G CST3 cystatin C ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:52,834,497...52,838,785
Ensembl chr 2:52,832,181...52,838,865
JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10445756 NCBI chr26:8,727,996...8,733,254 JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27736846 NCBI chr 9:88,154,131...88,183,915
Ensembl chr 9:88,154,134...88,183,458
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11740344 PMID:19925388 PMID:23104259 NCBI chr 9:88,082,124...88,125,390 JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23609392 NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18990727 NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
JBrowse link
G DHFR dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 4:74,787,292...74,811,196
Ensembl chr 4:74,787,629...74,810,960
JBrowse link
G DIP2B disco interacting protein 2 homolog B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:46,724,318...46,977,361
Ensembl chr11:46,724,384...46,973,543
JBrowse link
G DPYD dihydropyrimidine dehydrogenase ISO DNA:SNP:cds:rs12119882 (human) RGD PMID:28347776 RGD:152995291 NCBI chr20:35,376,738...36,215,388
Ensembl chr20:35,377,266...36,215,679
JBrowse link
G ENOSF1 enolase superfamily member 1 ISO DNA:SNP:cds:rs699517 (human) RGD PMID:28347776 RGD:152995291 NCBI chr18:60,042,711...60,080,954
Ensembl chr18:60,043,096...60,080,904
JBrowse link
G EPHA7 EPH receptor A7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30357299 NCBI chr13:18,097,051...18,283,664
Ensembl chr13:18,099,005...18,281,415
JBrowse link
G EPHX2 epoxide hydrolase 2 ISO CTD Direct Evidence: therapeutic CTD PMID:26165641 NCBI chr 8:25,603,668...25,659,232
Ensembl chr 8:25,603,735...25,659,345
JBrowse link
G ERCC1 ERCC excision repair 1, endonuclease non-catalytic subunit treatment ISO associated with Breast Neoplasms;DNA:SNP: :p.Q504K (human)
associated with Leukemia, Myeloid, Acute
RGD PMID:17197435 PMID:25495407 RGD:11252168 RGD:11252178 NCBI chr 6:38,857,067...38,900,177
Ensembl chr 6:38,854,803...38,872,967
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit treatment ISO DNA:SNP: :p.K751Q (rs13181) (human)
associated with Leukemia, Myeloid, Acute;DNA:SNPs, haplotypes: :p.D312N, p.K751Q (human)
RGD PMID:15339847 PMID:17197435 RGD:11252178 RGD:11252202 NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
JBrowse link
G FGA fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 7:101,127,554...101,134,881
Ensembl chr 7:101,125,791...101,134,405
JBrowse link
G FNDC3B fibronectin type III domain containing 3B ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr15:17,060,117...17,428,340
Ensembl chr15:17,059,959...17,428,339
JBrowse link
G GATA4 GATA binding protein 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr 8:7,348,145...7,432,574
Ensembl chr 8:7,349,660...7,400,562
JBrowse link
G GATA6 GATA binding protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31190750 NCBI chr18:58,312,328...58,345,472
Ensembl chr18:58,311,482...58,343,746
JBrowse link
G GC GC vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 PMID:24361871 PMID:28885000 NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
JBrowse link
G HMGB1 high mobility group box 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27474498 NCBI chr 3:9,353,333...9,357,765 JBrowse link
G HMOX1 heme oxygenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18227147 NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
JBrowse link
G HOMER1 homer scaffold protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr 4:73,591,105...73,729,680
Ensembl chr 4:73,589,495...73,728,353
JBrowse link
G HPX hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 1:58,385,860...58,396,269
Ensembl chr 1:58,386,190...58,396,298
JBrowse link
G HSPB6 heat shock protein family B (small) member 6 ISO CTD Direct Evidence: therapeutic CTD PMID:18948619 NCBI chr 6:30,664,355...30,666,841
Ensembl chr 6:30,665,315...30,666,802
JBrowse link
G HTR2B 5-hydroxytryptamine receptor 2B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16863450 NCBI chr10:117,132,919...117,152,132
Ensembl chr10:117,133,195...117,149,681
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:20064577 NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
JBrowse link
G IGFBP1 insulin like growth factor binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr21:12,932,727...12,939,078
Ensembl chr21:12,932,732...12,937,891
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
JBrowse link
G IL1RN interleukin 1 receptor antagonist ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
JBrowse link
G IL3 interleukin 3 ISO CTD Direct Evidence: therapeutic CTD PMID:8202718 NCBI chr23:34,894,630...34,899,105 JBrowse link
G IL6 interleukin 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:1720698 NCBI chr11:83,856,149...83,943,095
Ensembl chr11:83,856,157...83,943,083
JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
JBrowse link
G LOC103215401 arylamine N-acetyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:11505221 NCBI chr 8:16,302,296...16,315,406
Ensembl chr 8:16,314,446...16,315,318
JBrowse link
G LOC103218970 alpha-1-acid glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr12:25,257,002...25,261,255
Ensembl chr12:25,256,969...25,260,446
JBrowse link
G LTBR lymphotoxin beta receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr11:6,425,223...6,431,881
Ensembl chr11:6,425,324...6,433,583
JBrowse link
G MAPK14 mitogen-activated protein kinase 14 susceptibility ISO associated with lung non-small cell carcinoma;DNA:SNP:3' utr, intron: (rs3804451) (human) RGD PMID:26993769 RGD:151665351 NCBI chr17:36,012,164...36,095,542
Ensembl chr17:36,014,454...36,095,138
JBrowse link
G MOCOS molybdenum cofactor sulfurase ISO CTD Direct Evidence: marker/mechanism CTD PMID:29935280 NCBI chr18:44,570,277...44,627,641
Ensembl chr18:44,581,987...44,627,557
JBrowse link
G MTHFR methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:16166815 PMID:17387702 PMID:17502830 PMID:18551038 More... NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
JBrowse link
G MTR 5-methyltetrahydrofolate-homocysteine methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 PMID:19159907 NCBI chr25:73,935,666...74,039,872
Ensembl chr25:73,935,225...74,038,741
JBrowse link
G MTRR 5-methyltetrahydrofolate-homocysteine methyltransferase reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 4:7,461,521...7,493,032
Ensembl chr 4:7,461,526...7,493,840
JBrowse link
G NAT2 N-acetyltransferase 2 susceptibility ISO DNA:polymorphism: :
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12786839 PMID:17377643 PMID:17502830 RGD:8552667 NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 ISO CTD Direct Evidence: therapeutic CTD PMID:20605904 NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
JBrowse link
G NR3C1 nuclear receptor subfamily 3 group C member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29802709 NCBI chr23:45,904,926...46,031,804
Ensembl chr23:45,904,873...46,031,125
JBrowse link
G NT5C2 5'-nucleotidase, cytosolic II ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr 9:96,133,873...96,325,122
Ensembl chr 9:96,135,400...96,219,956
JBrowse link
G PELI1 pellino E3 ubiquitin protein ligase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154 NCBI chr14:42,864,857...42,930,315
Ensembl chr14:42,864,897...42,930,394
JBrowse link
G PLG plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr13:88,266,054...88,321,596
Ensembl chr13:88,268,198...88,322,644
JBrowse link
G PLK2 polo like kinase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12897130 NCBI chr 4:54,629,868...54,636,134
Ensembl chr 4:54,629,194...54,636,032
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:19683050
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10698006 NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
JBrowse link
G REN renin ISO CTD Direct Evidence: marker/mechanism CTD PMID:8723173 NCBI chr25:25,159,816...25,193,620
Ensembl chr25:25,183,037...25,193,420
JBrowse link
G SERPINA1 serpin family A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
JBrowse link
G SHMT1 serine hydroxymethyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr16:17,371,704...17,408,499 JBrowse link
G SLC19A1 solute carrier family 19 member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21064136 NCBI chr 2:89,188,171...89,232,081
Ensembl chr 2:89,188,733...89,209,281
JBrowse link
G SLC22A7 solute carrier family 22 member 7 ISO DNA:SNP:cds:rs2270860|rs4149178 (human) RGD PMID:28347776 RGD:152995291 NCBI chr17:28,848,115...28,856,298
Ensembl chr17:28,846,791...28,855,355
JBrowse link
G SLC34A2 solute carrier family 34 member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr27:24,674,419...24,698,844
Ensembl chr27:24,674,584...24,690,984
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21387541 NCBI chr11:20,992,353...21,091,761
Ensembl chr11:21,001,655...21,093,278
JBrowse link
G SLCO2A1 solute carrier organic anion transporter family member 2A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr15:56,339,585...56,427,196
Ensembl chr15:56,339,744...56,430,032
JBrowse link
G SOD1 superoxide dismutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr 2:60,461,219...60,472,999 JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15805072 NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
JBrowse link
G TCN2 transcobalamin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15753437 NCBI chr19:13,489,849...13,511,360
Ensembl chr19:13,490,645...13,511,810
JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr15:56,586,311...56,618,304
Ensembl chr15:56,586,104...56,618,149
JBrowse link
G THBD thrombomodulin ISO CTD Direct Evidence: therapeutic CTD PMID:27474498 NCBI chr 2:52,041,950...52,045,946
Ensembl chr 2:52,043,746...52,045,626
JBrowse link
G TLR1 toll like receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr27:11,482,307...11,490,847
Ensembl chr27:11,488,294...11,490,654
JBrowse link
G TLR2 toll like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 PMID:31557154 NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31557154
G TOP1 DNA topoisomerase I ISO CTD Direct Evidence: marker/mechanism CTD PMID:19931604 NCBI chr 2:22,655,085...22,751,082
Ensembl chr 2:22,651,995...22,751,102
JBrowse link
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:9369336 NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
JBrowse link
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:28885000 NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
JBrowse link
G TXN thioredoxin ISO CTD Direct Evidence: therapeutic CTD PMID:11462148 NCBI chr12:29,296,166...29,308,979 JBrowse link
G TYMS thymidylate synthetase ISO CTD Direct Evidence: marker/mechanism
DNA:SNP:cds:rs2853741 (human)
CTD
RGD
PMID:19648163 PMID:21064136 PMID:25007187 PMID:26077125 PMID:28347776 RGD:152995291 NCBI chr18:60,030,640...60,043,297
Ensembl chr18:60,030,658...60,041,856
JBrowse link
G UMPS uridine monophosphate synthetase ISO DNA:SNP:cds:rs2279199|rs4678145 (human) RGD PMID:28347776 RGD:152995291 NCBI chr22:56,081,897...56,097,164
Ensembl chr22:56,082,103...56,097,105
JBrowse link
G VEGFA vascular endothelial growth factor A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31068094 NCBI chr17:28,377,959...28,394,508 JBrowse link
G VKORC1 vitamin K epoxide reductase complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26445138 NCBI chr 5:27,778,553...27,782,639
Ensembl chr 5:27,776,416...27,782,640
JBrowse link
Anthracycline-induced Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCB1 ATP binding cassette subfamily B member 1 susceptibility ISO DNA:missense mutation:cds:p.G671V (human) RGD PMID:16330681 RGD:11041175 NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
JBrowse link
G ACVR2B activin A receptor type 2B treatment ISO human construct in mouse model RGD PMID:30765322 RGD:329849112 NCBI chr15:923,222...962,438 JBrowse link
G CAPN2 calpain 2 treatment ISO RGD PMID:25634181 RGD:13792617 NCBI chr25:5,845,873...5,905,464
Ensembl chr25:5,846,298...5,905,402
JBrowse link
G ERCC2 ERCC excision repair 2, TFIIH core complex helicase subunit ISO associated with Leukemia, Myeloid, Acute;DNA:SNP:exon:p.K751Q (rs13181) (human) RGD PMID:24284041 RGD:11252190 NCBI chr 6:38,804,296...38,823,229
Ensembl chr 6:38,801,423...38,823,073
JBrowse link
aspirin-induced respiratory disease term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CACNG6 calcium voltage-gated channel auxiliary subunit gamma 6 susceptibility ISO DNA:SNP,haplotype:rs192808(human) RGD PMID:20860846 RGD:13524562 NCBI chr 6:46,680,827...46,700,959
Ensembl chr 6:46,682,088...46,700,938
JBrowse link
G CCR3 C-C motif chemokine receptor 3 ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:20022477 PMID:20485159 RGD:4145619 NCBI chr22:7,648,410...7,698,523
Ensembl chr22:7,697,068...7,698,135
JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 PMID:17641958 PMID:20485159
G CYSLTR2 cysteinyl leukotriene receptor 2 ISO DNA:SNPs: :-819T>G, 2078C>T, 2534A>G (human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:15970796 PMID:16502481 PMID:20485159 RGD:5144000 NCBI chr 3:26,578,248...26,624,364 JBrowse link
G FANCC FA complementation group C ISO DNA:haplotype::rs4647416(human) RGD PMID:21670957 RGD:11045795 NCBI chr12:107,780,087...107,991,828
Ensembl chr12:107,845,135...107,991,237
JBrowse link
G IL4 interleukin 4 susceptibility ISO DNA:SNPs:promoter,5'UTR,intron:multiple RGD PMID:20921925 RGD:11528633 NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
JBrowse link
G LOC103233689 thromboxane A2 receptor susceptibility ISO DNA:polymorphism: :795T>C (human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:15898979 PMID:16502481 PMID:20485159 RGD:11059537 NCBI chr 6:3,354,358...3,365,779
Ensembl chr 6:3,355,314...3,359,761
JBrowse link
G LTC4S leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:9393345 PMID:9466979 PMID:10970818 PMID:20485159 NCBI chr23:81,523,784...81,526,297
Ensembl chr23:81,523,775...81,526,179
JBrowse link
G MHC-DPB1 major histocompatibility complex, class II, DP beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr17:38,996,329...39,007,097 JBrowse link
G MHC-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility ISO RGD PMID:25975240 RGD:11074090 NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
JBrowse link
G MS4A2 membrane spanning 4-domains A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 1:13,657,842...13,666,314
Ensembl chr 1:13,654,696...13,665,925
JBrowse link
G POSTN periostin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr 3:16,060,013...16,095,867
Ensembl chr 3:16,059,965...16,095,791
JBrowse link
G PTGDR2 prostaglandin D2 receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 1:12,989,750...12,994,979
Ensembl chr 1:12,992,188...12,993,378
JBrowse link
G PTGER2 prostaglandin E receptor 2 ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to ClinVar PMID:15496426 NCBI chr24:29,395,799...29,410,723
Ensembl chr24:29,396,464...29,409,575
JBrowse link
G PTGIR prostaglandin I2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 6:39,977,057...39,983,592
Ensembl chr 6:39,977,864...39,980,860
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 ISO protein:increased expression:mast cell
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9487340 PMID:16502481 PMID:20485159 RGD:5143936 NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
JBrowse link
G TAP2 transporter 2, ATP binding cassette subfamily B member ISO RGD PMID:21796142 RGD:5147839 NCBI chr17:39,266,870...39,277,658 JBrowse link
G TBX21 T-box transcription factor 21 ISO ClinVar Annotator: match by term: Asthma, aspirin-induced, susceptibility to ClinVar PMID:15806396 NCBI chr16:68,131,258...68,145,579
Ensembl chr16:68,131,536...68,144,415
JBrowse link
asthma, nasal polyps, and aspirin intolerance term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX15 arachidonate 15-lipoxygenase ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar PMID:17959182 PMID:21558275 PMID:30643255 NCBI chr16:4,112,795...4,121,764
Ensembl chr16:4,111,151...4,121,645
JBrowse link
G PTGER2 prostaglandin E receptor 2 susceptibility ISO CTD Direct Evidence: marker/mechanism OMIM
CTD
NCBI chr24:29,395,799...29,410,723
Ensembl chr24:29,396,464...29,409,575
JBrowse link
G TBX21 T-box transcription factor 21 ISO ClinVar Annotator: match by term: Asthma, nasal polyps, and aspirin intolerance ClinVar
OMIM
PMID:25741868 NCBI chr16:68,131,258...68,145,579
Ensembl chr16:68,131,536...68,144,415
JBrowse link
Cardiotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACACB acetyl-CoA carboxylase beta ISO mRNA, protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr11:104,325,250...104,488,567
Ensembl chr11:104,349,573...104,488,003
JBrowse link
G AGT angiotensinogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:33676887 NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
JBrowse link
G BCHE butyrylcholinesterase ISO CTD Direct Evidence: therapeutic CTD PMID:26145887 NCBI chr15:23,708,121...23,778,027
Ensembl chr15:23,708,155...23,778,286
JBrowse link
G BMP2 bone morphogenetic protein 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29800642 NCBI chr 2:31,349,394...31,361,227
Ensembl chr 2:31,348,808...31,360,901
JBrowse link
G CAT catalase ISO CTD Direct Evidence: therapeutic CTD PMID:35792220 NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
JBrowse link
G CCL2 C-C motif chemokine ligand 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA, protein:decreased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 1:5,704,275...5,784,077
Ensembl chr 1:5,730,853...5,784,337
JBrowse link
G CSF1 colony stimulating factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr20:23,615,107...23,635,399 JBrowse link
G CXCL8 C-X-C motif chemokine ligand 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 7:22,202,497...22,205,730
Ensembl chr 7:22,202,527...22,204,068
JBrowse link
G FASLG Fas ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:34713381 NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
JBrowse link
G FTO FTO alpha-ketoglutarate dependent dioxygenase ISO DNA:hypermethylation:promoter RGD PMID:35462195 RGD:329951017 NCBI chr 5:39,487,304...39,900,238
Ensembl chr 5:39,487,418...39,725,747
JBrowse link
G HBEGF heparin binding EGF like growth factor ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr23:42,981,640...42,995,116
Ensembl chr23:42,981,640...42,994,995
JBrowse link
G IL1B interleukin 1 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:32068018 NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
JBrowse link
G METTL14 methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:34648132 NCBI chr 7:66,169,080...66,195,324
Ensembl chr 7:66,168,855...66,194,121
JBrowse link
G MLYCD malonyl-CoA decarboxylase ISO protein:increased expression:heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr 5:69,312,978...69,329,346
Ensembl chr 5:69,313,062...69,329,102
JBrowse link
G NOS3 nitric oxide synthase 3 treatment ISO associated with Precursor Cell Lymphoblastic Leukemia-Lymphoma;DNA:polymorphism: :894G>T(human) RGD PMID:26345518 RGD:11533645 NCBI chr21:119,174,829...119,196,840 JBrowse link
G NPPB natriuretic peptide B ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr20:119,930,931...119,933,391
Ensembl chr20:119,932,021...119,933,197
JBrowse link
G NRG1 neuregulin 1 ISO CTD Direct Evidence: therapeutic CTD PMID:29305325 NCBI chr 8:29,745,984...30,862,140
Ensembl chr 8:30,635,803...30,856,487
JBrowse link
G PRKAA2 protein kinase AMP-activated catalytic subunit alpha 2 ISO protein:decreased expression:serum, heart (rat) RGD PMID:30644033 RGD:329955369 NCBI chr20:76,258,063...76,319,512
Ensembl chr20:76,259,763...76,319,430
JBrowse link
G RAC1 Rac family small GTPase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28710503 NCBI chr28:15,583,609...15,610,753
Ensembl chr28:15,583,516...15,610,328
JBrowse link
G RARG retinoic acid receptor gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:26237429 NCBI chr11:49,319,104...49,340,725
Ensembl chr11:49,319,839...49,328,656
JBrowse link
G RNF10 ring finger protein 10 ISO CTD Direct Evidence: therapeutic CTD PMID:36740146 NCBI chr11:115,888,359...115,930,790
Ensembl chr11:115,893,457...115,930,848
JBrowse link
G SIRT6 sirtuin 6 ISO CTD Direct Evidence: therapeutic CTD PMID:34713381 NCBI chr 6:3,924,230...3,932,583
Ensembl chr 6:3,924,230...3,932,590
JBrowse link
G TLR2 toll like receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 NCBI chr 7:100,239,533...100,565,955
Ensembl chr 7:100,258,441...100,260,795
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:29959987 PMID:32068018
G TP53 tumor protein p53 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30009776 PMID:34713381 NCBI chr16:7,047,686...7,065,567
Ensembl chr16:7,045,146...7,066,223
JBrowse link
Chemical and Drug Induced Liver Injury term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G AASS aminoadipate-semialdehyde synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr21:90,891,781...90,959,351
Ensembl chr21:90,892,023...90,959,343
JBrowse link
G ABCB1 ATP binding cassette subfamily B member 1 severity
susceptibility
ISO DNA:SNP::2677G>T/A(rs2032582)(human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:20623750 PMID:26134275 PMID:27296832 RGD:11041130 RGD:14700895 NCBI chr21:61,211,044...61,430,691
Ensembl chr21:61,322,748...61,529,274
JBrowse link
G ABCB11 ATP binding cassette subfamily B member 11 severity ISO DNA:SNP: :rs2287616(human) RGD PMID:27293027 RGD:14402413 NCBI chr10:54,458,283...54,575,943
Ensembl chr10:54,459,377...54,575,059
JBrowse link
G ABCC1 ATP binding cassette subfamily C member 1 (ABCC1 blood group) ISO CTD Direct Evidence: marker/mechanism CTD PMID:18466103 NCBI chr 5:14,972,589...15,164,594
Ensembl chr 5:14,972,646...15,164,567
JBrowse link
G ABCC2 ATP binding cassette subfamily C member 2 susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:polymorphism:promoter:-24C>T(human)
CTD
RGD
PMID:17241877 PMID:18381794 PMID:18466103 PMID:25196354 RGD:14700812 RGD:14700814 NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
JBrowse link
G ABI1 abl interactor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:26,377,822...26,495,665
Ensembl chr 9:26,379,516...26,495,676
JBrowse link
G ACOX3 acyl-CoA oxidase 3, pristanoyl ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr27:44,313,297...44,366,702 JBrowse link
G ACSL1 acyl-CoA synthetase long chain family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:130,712,633...130,783,360
Ensembl chr 7:130,712,308...130,763,756
JBrowse link
G ACTB actin beta ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:liver
CTD
RGD
PMID:22563491 PMID:25231249 RGD:9587759 NCBI chr28:16,195,676...16,197,161
Ensembl chr12:52,426,752...52,427,879
JBrowse link
G ACTN4 actinin alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:33,290,639...33,373,059
Ensembl chr 6:33,290,622...33,374,693
JBrowse link
G ACTR3 actin related protein 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:16,296,350...16,369,561
Ensembl chr10:16,297,502...16,369,220
JBrowse link
G ADA adenosine deaminase ISO protein:increased expression:liver RGD PMID:21161045 RGD:5128859 NCBI chr 2:19,167,209...19,200,233 JBrowse link
G ADAM8 ADAM metallopeptidase domain 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24646716 NCBI chr26:53,114,184...53,129,650
Ensembl chr26:53,114,924...53,126,900
JBrowse link
G ADIPOQ adiponectin, C1Q and collagen domain containing ISO CTD Direct Evidence: therapeutic CTD PMID:20709802 NCBI chr15:81,128,427...81,142,779
Ensembl chr15:81,129,795...81,147,391
JBrowse link
G ADIPOR2 adiponectin receptor 2 severity ISO associated with obesity, LPS;mRNA:decreased expression:liver (rat) RGD PMID:23838384 RGD:8695926 NCBI chr11:1,802,694...1,836,703
Ensembl chr11:1,738,026...1,837,060
JBrowse link
G ADORA2B adenosine A2b receptor ISO CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr16:15,682,669...15,712,079
Ensembl chr16:15,683,077...15,711,858
JBrowse link
G AGT angiotensinogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:29499335 NCBI chr25:67,964,840...67,977,006
Ensembl chr25:67,962,401...67,973,324
JBrowse link
G AHR aryl hydrocarbon receptor ISO CTD Direct Evidence: marker/mechanism|therapeutic
mRNA:decreased expression:liver (rat)
CTD
RGD
PMID:21890736 PMID:28959666 PMID:34848246 RGD:401794432 NCBI chr21:40,778,198...40,826,491
Ensembl chr21:40,778,218...40,826,478
JBrowse link
G AIFM1 apoptosis inducing factor mitochondria associated 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25743375 NCBI chr  X:105,383,408...105,419,146
Ensembl chr  X:105,382,693...105,419,095
JBrowse link
G AK4 adenylate kinase 4 ISO protein:increased expression:liver (rat) RGD PMID:16538043 RGD:2301096 NCBI chr20:67,840,572...67,924,691 JBrowse link
G AKR1A1 aldo-keto reductase family 1 member A1 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:29763686 PMID:32805337 RGD:27226688 NCBI chr20:87,228,348...87,245,511
Ensembl chr20:87,228,189...87,245,466
JBrowse link
G ALB albumin treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:18779383 PMID:22310181 PMID:27567545 RGD:14694844 NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
JBrowse link
G ALDH1L2 aldehyde dehydrogenase 1 family member L2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:100,242,649...100,311,164
Ensembl chr11:100,247,262...100,298,621
JBrowse link
G ALDH2 aldehyde dehydrogenase 2 family member severity
susceptibility
ISO DNA:deletion:exon 3 (mouse)
protein:increased expression:liver
RGD PMID:21138988 PMID:24492981 PMID:30121625 RGD:14975148 RGD:15036810 RGD:7241599 NCBI chr11:107,019,015...107,060,784
Ensembl chr11:107,019,111...107,060,374
JBrowse link
G ALDH9A1 aldehyde dehydrogenase 9 family member A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr25:63,184,220...63,223,865 JBrowse link
G ALDOB aldolase, fructose-bisphosphate B ISO CTD Direct Evidence: marker/mechanism CTD PMID:16115720 NCBI chr12:37,993,367...38,021,693
Ensembl chr12:38,007,265...38,021,258
JBrowse link
G AMBP alpha-1-microglobulin/bikunin precursor ISO CTD Direct Evidence: marker/mechanism CTD PMID:18779383 NCBI chr12:25,508,516...25,526,821
Ensembl chr12:25,508,682...25,527,016
JBrowse link
G ANXA2 annexin A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr26:23,100,000...23,147,687
Ensembl chr26:23,099,992...23,145,457
JBrowse link
G ANXA6 annexin A6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr23:53,657,377...53,714,828
Ensembl chr23:53,657,718...53,714,850
JBrowse link
G APOA1 apolipoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
JBrowse link
G APOE apolipoprotein E ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 6:38,377,154...38,381,219
Ensembl chr 6:38,376,887...38,381,438
JBrowse link
G APOH apolipoprotein H ISO CTD Direct Evidence: marker/mechanism
mRNA:increased expression:plasma:
CTD
RGD
PMID:16099942 PMID:23288050 RGD:10054107 NCBI chr16:55,209,142...55,231,176 JBrowse link
G ARG1 arginase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22872058 NCBI chr13:41,971,955...41,983,372
Ensembl chr13:41,971,802...41,983,049
JBrowse link
G ARNT aryl hydrocarbon receptor nuclear translocator ISO CTD Direct Evidence: marker/mechanism CTD PMID:20935161
G ATG5 autophagy related 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22491424 NCBI chr13:67,482,538...67,619,201
Ensembl chr13:67,482,595...67,617,902
JBrowse link
G ATOH8 atonal bHLH transcription factor 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:21,368,197...21,402,650 JBrowse link
G ATP6V1D ATPase H+ transporting V1 subunit D ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr24:44,578,057...44,598,918
Ensembl chr24:44,578,807...44,598,394
JBrowse link
G BAD BCL2 associated agonist of cell death treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr 1:9,949,717...9,964,433
Ensembl chr 1:9,949,762...9,964,432
JBrowse link
G BAX BCL2 associated X, apoptosis regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:17906064 NCBI chr 6:42,186,028...42,193,105 JBrowse link
G BDH1 3-hydroxybutyrate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:89,678,844...89,741,848
Ensembl chr15:89,707,046...89,742,434
JBrowse link
G BDKRB2 bradykinin receptor B2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30685357 NCBI chr24:74,084,907...74,125,604
Ensembl chr24:74,118,210...74,122,909
JBrowse link
G BLVRB biliverdin reductase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:34,902,632...34,925,105
Ensembl chr 6:34,902,598...34,925,100
JBrowse link
G BMAL1 basic helix-loop-helix ARNT like 1 ISO CTD Direct Evidence: therapeutic CTD PMID:36602574 NCBI chr 1:51,430,670...51,540,344
Ensembl chr 1:51,431,180...51,462,674
JBrowse link
G BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr25:9,489,479...9,518,936
Ensembl chr25:9,490,763...9,519,721
JBrowse link
G BRD4 bromodomain containing 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:13,836,332...13,883,459
Ensembl chr 6:13,836,324...13,873,877
JBrowse link
G BTD biotinidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:15469856 NCBI chr15:60,433,035...60,470,600
Ensembl chr15:60,459,913...60,470,615
JBrowse link
G C3 complement C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 6:6,250,422...6,289,264 JBrowse link
G CA3 carbonic anhydrase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 PMID:25231249 NCBI chr 8:80,805,296...80,816,127
Ensembl chr 8:80,805,134...80,816,190
JBrowse link
G CABP1 calcium binding protein 1 ISO protein:increased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr11:115,934,747...116,021,645 JBrowse link
G CADPS2 calcium dependent secretion activator 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr21:91,117,749...91,669,284 JBrowse link
G CANX calnexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr23:81,422,701...81,454,683
Ensembl chr23:81,422,693...81,482,332
JBrowse link
G CAP1 cyclase associated actin cytoskeleton regulatory protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:92,833,112...92,865,258
Ensembl chr20:92,829,735...92,864,697
JBrowse link
G CASP8 caspase 8 treatment ISO RGD PMID:25447754 RGD:10053709 NCBI chr10:86,888,654...86,944,159
Ensembl chr10:86,916,527...86,943,829
JBrowse link
G CAST calpastatin ISO RGD PMID:16871587 RGD:5683869 NCBI chr 4:90,496,867...90,607,019
Ensembl chr 4:90,497,754...90,605,481
JBrowse link
G CAT catalase ISO protein:decreased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:20623750 PMID:21138988 PMID:25231249 RGD:7241599 NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
JBrowse link
G CCDC80 coiled-coil domain containing 80 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513
G CCL2 C-C motif chemokine ligand 2 treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:20623750 PMID:21813474 PMID:30663942 RGD:14995458 RGD:14995466 NCBI chr16:27,763,354...27,765,437
Ensembl chr16:27,763,555...27,765,416
JBrowse link
G CCR2 C-C motif chemokine receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr22:7,795,192...7,801,242
Ensembl chr22:7,798,646...7,799,728
JBrowse link
G CCR5 C-C motif chemokine receptor 5 susceptibility ISO acetaminophen RGD PMID:24770590 RGD:14401733 NCBI chr22:7,803,794...7,818,112 JBrowse link
G CCT3 chaperonin containing TCP1 subunit 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:7,518,729...7,545,296
Ensembl chr20:7,518,846...7,545,677
JBrowse link
G CCT5 chaperonin containing TCP1 subunit 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:9,787,093...9,802,892
Ensembl chr 4:9,787,101...9,805,852
JBrowse link
G CDC25B cell division cycle 25B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:34,482,709...34,493,737
Ensembl chr 2:34,483,771...34,494,071
JBrowse link
G CDS1 CDP-diacylglycerol synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:32,947,644...33,014,807
Ensembl chr 7:32,948,053...33,014,944
JBrowse link
G CELA1 chymotrypsin like elastase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:47,526,354...47,545,390
Ensembl chr11:47,526,365...47,544,726
JBrowse link
G CFAP20 cilia and flagella associated protein 20 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:44,047,860...44,063,605
Ensembl chr 5:44,047,464...44,063,738
JBrowse link
G CFH complement factor H ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr25:32,557,697...32,744,763 JBrowse link
G CHRM3 cholinergic receptor muscarinic 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20197374 NCBI chr25:76,772,212...77,009,433
Ensembl chr25:77,001,477...77,003,249
JBrowse link
G CKB creatine kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr24:81,462,164...81,463,873 JBrowse link
G CLU clusterin ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
JBrowse link
G COL14A1 collagen type XIV alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 8:114,701,662...114,946,216
Ensembl chr 8:114,701,664...114,887,483
JBrowse link
G COL3A1 collagen type III alpha 1 chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:16679477 NCBI chr10:74,455,133...74,493,392 JBrowse link
G COMT catechol-O-methyltransferase ISO protein:decreased expression:liver RGD PMID:21138988 RGD:7241599 NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
JBrowse link
G COQ9 coenzyme Q9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 5:43,378,467...43,393,037
Ensembl chr 5:43,378,539...43,392,384
JBrowse link
G CPB2 carboxypeptidase B2 ISO mRNA,protein:increased expression,increased activity:liver,plasma RGD PMID:19386599 RGD:7243112 NCBI chr 3:24,108,854...24,161,669
Ensembl chr 3:24,109,416...24,161,408
JBrowse link
G CPS1 carbamoyl-phosphate synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr10:96,267,890...96,392,393
Ensembl chr10:96,267,889...96,392,206
JBrowse link
G CPT1A carnitine palmitoyltransferase 1A ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr 1:5,704,275...5,784,077
Ensembl chr 1:5,730,853...5,784,337
JBrowse link
G CRP C-reactive protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:20005281 NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: therapeutic CTD PMID:19679878 NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
JBrowse link
G CTSE cathepsin E ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr25:23,318,421...23,333,885
Ensembl chr25:23,319,248...23,332,980
JBrowse link
G CXCL1 C-X-C motif chemokine ligand 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16118408 NCBI chr 7:22,327,041...22,329,405
Ensembl chr 7:22,569,355...22,569,900
Ensembl chr 7:22,569,355...22,569,900
JBrowse link
G CXCL10 C-X-C motif chemokine ligand 10 ISO CTD Direct Evidence: therapeutic CTD PMID:11739529 NCBI chr 7:24,526,657...24,529,193
Ensembl chr 7:24,526,680...24,529,130
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr26:8,727,996...8,733,254 JBrowse link
G CYP1B1 cytochrome P450 family 1 subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33814510 NCBI chr14:69,318,713...69,327,277
Ensembl chr14:69,319,495...69,324,157
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 ISO mRNA, protein:decreased expression:kidney (mouse) RGD PMID:26476181 RGD:25671412 NCBI chr11:53,675,704...53,681,372
Ensembl chr11:53,675,226...53,680,443
JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 PMID:33814510 NCBI chr 6:35,392,699...35,418,171
Ensembl chr 6:35,393,342...35,418,106
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 ISO CTD Direct Evidence: marker/mechanism CTD PMID:12963435 PMID:28762043 NCBI chr 9:87,981,300...88,025,007 JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14971821 PMID:21741958 PMID:25226513 PMID:28762043 PMID:33814510 NCBI chr 9:88,082,124...88,125,390 JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO DNA:hypermethylation:promoter RGD PMID:27490558 RGD:14700879 NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 treatment ISO associated with Endotoxemia
DNA:hypermethylation:promoter
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:12668988 PMID:16770646 PMID:21741958 PMID:25681370 PMID:27324775 More... RGD:14700872 RGD:14700873 RGD:14700878 RGD:14700879 RGD:14700901 NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
JBrowse link
G CYP8B1 cytochrome P450 family 8 subfamily B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25448281 NCBI chr22:4,323,840...4,326,459
Ensembl chr22:4,324,396...4,325,901
JBrowse link
G DBT dihydrolipoamide branched chain transacylase E2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:33,088,452...33,157,693
Ensembl chr20:33,088,496...33,140,403
JBrowse link
G DDB1 damage specific DNA binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:12,508,712...12,543,127
Ensembl chr 1:12,508,443...12,544,913
JBrowse link
G DGAT2 diacylglycerol O-acyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 1:66,985,413...67,018,058
Ensembl chr 1:66,985,466...67,021,182
JBrowse link
G DHFR dihydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19648163 NCBI chr 4:74,787,292...74,811,196
Ensembl chr 4:74,787,629...74,810,960
JBrowse link
G DHRS7 dehydrogenase/reductase 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr24:37,368,792...37,389,433
Ensembl chr24:37,368,982...37,389,403
JBrowse link
G DLAT dihydrolipoamide S-acetyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:103,379,165...103,419,585
Ensembl chr 1:103,380,426...103,420,386
JBrowse link
G DNAJB9 DnaJ heat shock protein family (Hsp40) member B9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr21:77,477,177...77,482,190
Ensembl chr21:77,479,112...77,482,571
JBrowse link
G DNAJC12 DnaJ heat shock protein family (Hsp40) member C12 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 9:63,545,032...63,588,391
Ensembl chr 9:63,545,045...63,588,401
JBrowse link
G DSC2 desmocollin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr18:49,596,870...49,637,587
Ensembl chr18:49,599,940...49,639,526
JBrowse link
G E2F1 E2F transcription factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 2:37,968,541...37,980,461
Ensembl chr 2:37,968,556...37,980,326
JBrowse link
G ECHDC1 ethylmalonyl-CoA decarboxylase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr13:46,386,543...46,440,730
Ensembl chr13:46,398,058...46,439,533
JBrowse link
G ECHS1 enoyl-CoA hydratase, short chain 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr26:53,212,299...53,222,805 JBrowse link
G EDEM1 ER degradation enhancing alpha-mannosidase like protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr22:41,253,861...41,286,185
Ensembl chr22:41,253,989...41,282,140
JBrowse link
G EIF2AK1 eukaryotic translation initiation factor 2 alpha kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25411909 NCBI chr28:15,225,768...15,269,692
Ensembl chr28:15,233,909...15,269,594
JBrowse link
G EIF4EBP2 eukaryotic translation initiation factor 4E binding protein 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:60,867,810...60,894,899
Ensembl chr 9:60,874,602...60,894,919
JBrowse link
G ENDOG endonuclease G ISO protein:decreased expression:mitochondrion: RGD PMID:22509279 RGD:9685364 NCBI chr12:9,322,828...9,326,833
Ensembl chr12:9,322,892...9,326,549
JBrowse link
G ENG endoglin ISO protein:increased expression:liver (rat) RGD PMID:21146604 RGD:7257529 NCBI chr12:10,274,705...10,315,715
Ensembl chr12:10,275,064...10,315,040
JBrowse link
G ENO1 enolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:25231249 NCBI chr20:122,884,846...122,902,669
Ensembl chr20:122,884,727...122,903,372
JBrowse link
G ENPP2 ectonucleotide pyrophosphatase/phosphodiesterase 2 ISO protein:increased activity:serum: RGD PMID:17850827 RGD:9685426 NCBI chr 8:114,113,780...114,232,656
Ensembl chr 8:114,113,778...114,195,956
JBrowse link
G EPHX1 epoxide hydrolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr25:3,924,396...3,960,264
Ensembl chr25:3,924,606...3,945,535
JBrowse link
G ERLEC1 endoplasmic reticulum lectin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr14:53,150,627...53,188,821
Ensembl chr14:53,154,556...53,188,538
JBrowse link
G ERN1 endoplasmic reticulum to nucleus signaling 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30538632 NCBI chr16:57,145,080...57,233,757
Ensembl chr16:57,145,191...57,236,230
JBrowse link
G F13A1 coagulation factor XIII A chain ISO RGD PMID:22019897 RGD:11041813 NCBI chr17:65,885,498...66,040,026
Ensembl chr17:65,885,658...66,040,040
JBrowse link
G F2RL3 F2R like thrombin or trypsin receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 6:15,397,552...15,400,708 JBrowse link
G F3 coagulation factor III, tissue factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22407844 NCBI chr20:38,726,690...38,738,457
Ensembl chr20:38,726,798...38,739,408
JBrowse link
G FADD Fas associated via death domain treatment ISO RGD PMID:25447754 PMID:26062544 RGD:10053709 RGD:11341803 NCBI chr 1:4,358,314...4,361,863 JBrowse link
G FADS1 fatty acid desaturase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:12,037,173...12,051,907
Ensembl chr 1:12,037,513...12,055,159
JBrowse link
G FADS2 fatty acid desaturase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:11,934,352...11,978,355
Ensembl chr 1:11,934,270...11,974,030
JBrowse link
G FASN fatty acid synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr16:73,988,410...74,008,374
Ensembl chr16:73,982,899...74,006,551
JBrowse link
G FCMR Fc mu receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr25:22,435,252...22,453,582
Ensembl chr25:22,435,339...22,447,732
JBrowse link
G FGA fibrinogen alpha chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:20974703 NCBI chr 7:101,127,554...101,134,881
Ensembl chr 7:101,125,791...101,134,405
JBrowse link
G FGF21 fibroblast growth factor 21 severity ISO mRNA:increased expression:liver (rat) RGD PMID:29883717 RGD:15045603 NCBI chr 6:42,006,125...42,008,749
Ensembl chr 6:42,006,064...42,008,736
JBrowse link
G FLT1 fms related receptor tyrosine kinase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21135413 NCBI chr 3:7,412,506...7,608,122
Ensembl chr 3:7,412,172...7,607,967
JBrowse link
G FMO3 flavin containing dimethylaniline monoxygenase 3 ISO CTD Direct Evidence: therapeutic CTD PMID:24973094 NCBI chr25:57,971,737...57,995,850
Ensembl chr25:57,969,234...57,995,613
JBrowse link
G FTL ferritin light chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 6:42,196,682...42,198,575
Ensembl chr 6:42,196,538...42,199,614
JBrowse link
G G6PC1 glucose-6-phosphatase catalytic subunit 1 ISO mRNA:decreased expression:liver (mouse) RGD PMID:28189721 RGD:14695531 NCBI chr16:63,380,921...63,392,122
Ensembl chr16:63,381,382...63,391,540
JBrowse link
G G6PD glucose-6-phosphate dehydrogenase treatment ISO RGD PMID:21864513 RGD:10449168 NCBI chr  X:128,768,028...128,788,366
Ensembl chr  X:128,770,268...128,786,961
JBrowse link
G GADD45A growth arrest and DNA damage inducible alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr20:65,422,668...65,425,845
Ensembl chr20:65,422,451...65,425,840
JBrowse link
G GANAB glucosidase II alpha subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:11,257,867...11,279,534
Ensembl chr 1:11,257,935...11,281,111
JBrowse link
G GC GC vitamin D binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
JBrowse link
G GCLC glutamate-cysteine ligase catalytic subunit ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:17573345 PMID:19481141 RGD:10402383 NCBI chr17:19,012,994...19,060,617
Ensembl chr17:19,013,026...19,060,659
JBrowse link
G GCLM glutamate-cysteine ligase modifier subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:39,339,948...39,359,980
Ensembl chr20:39,339,908...39,359,430
JBrowse link
G GDA guanine deaminase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:83,195,746...83,305,181
Ensembl chr12:83,195,994...83,306,792
JBrowse link
G GDI1 GDP dissociation inhibitor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249
G GFER growth factor, augmenter of liver regeneration treatment ISO RGD PMID:15968720 PMID:22033404 RGD:9685722 RGD:9685727 NCBI chr 5:1,880,025...1,886,829
Ensembl chr 5:1,879,968...1,883,696
JBrowse link
G GGH gamma-glutamyl hydrolase ISO CTD Direct Evidence: marker/mechanism CTD PMID:21219404 NCBI chr 8:58,908,524...58,932,885
Ensembl chr 8:58,908,417...58,932,685
JBrowse link
G GLUD1 glutamate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:33483742 NCBI chr 9:44,653,044...44,690,142
Ensembl chr 9:44,653,289...44,688,954
JBrowse link
G GOT1 glutamic-oxaloacetic transaminase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:92,463,017...92,489,227
Ensembl chr 9:92,462,782...92,488,310
JBrowse link
G GPD1 glycerol-3-phosphate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:46,329,479...46,339,227
Ensembl chr11:46,331,569...46,337,439
JBrowse link
G GPT glutamic--pyruvic transaminase treatment ISO CTD Direct Evidence: marker/mechanism
protein:increased expression, activity:serum:
RGD
CTD
PMID:145039 PMID:19085960 PMID:19481104 PMID:21772750 PMID:27293452 More... RGD:14975162 RGD:14975166 RGD:14975168 RGD:14975249 NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
JBrowse link
G GPT2 glutamic--pyruvic transaminase 2 ISO protein:increased expression, activity:serum: RGD PMID:19085960 RGD:14975249 NCBI chr 5:32,743,850...32,791,299
Ensembl chr 5:32,744,065...32,791,479
JBrowse link
G GRK4 G protein-coupled receptor kinase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr27:45,691,936...45,765,334 JBrowse link
G GSN gelsolin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr12:18,253,079...18,317,285
Ensembl chr12:18,253,324...18,285,938
JBrowse link
G GSR glutathione-disulfide reductase treatment ISO mRNA, protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:23554813 PMID:24154663 PMID:25226513 PMID:28069987 RGD:10401878 RGD:7257532 NCBI chr 8:28,778,713...28,851,907 JBrowse link
G GSTA4 glutathione S-transferase alpha 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr17:19,575,835...19,591,713
Ensembl chr17:19,575,876...19,591,919
JBrowse link
G GSTM3 glutathione S-transferase mu 3 ISO CTD Direct Evidence: therapeutic CTD PMID:25743375 NCBI chr20:23,797,794...23,802,910
Ensembl chr20:23,799,177...23,802,921
JBrowse link
G GSTO1 glutathione S-transferase omega 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:97,305,094...97,317,892 JBrowse link
G GSTP1 glutathione S-transferase pi 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:25226513 NCBI chr 1:6,676,897...6,679,936 JBrowse link
G H2AFX histone H2AX treatment ISO RGD PMID:23265463 RGD:8693741 NCBI chr 1:110,466,692...110,468,776
Ensembl chr 1:110,467,775...110,468,206
JBrowse link
G HACL1 2-hydroxyacyl-CoA lyase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr15:60,360,380...60,433,528
Ensembl chr15:60,322,722...60,433,647
JBrowse link
G HADHA hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:81,411,620...81,468,415
Ensembl chr14:81,411,648...81,472,257
JBrowse link
G HAMP hepcidin antimicrobial peptide ISO mRNA:increased expression:hepatocyte RGD PMID:24373749 RGD:11041724 NCBI chr 6:30,214,820...30,218,100
Ensembl chr 6:30,215,563...30,217,996
JBrowse link
G HAO2 hydroxyacid oxidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:14,376,096...14,408,753
Ensembl chr20:14,374,543...14,407,992
JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
JBrowse link
G HMGB1 high mobility group box 1 treatment ISO CTD Direct Evidence: marker/mechanism RGD
CTD
PMID:19783637 PMID:29091898 RGD:15090820 NCBI chr 3:9,353,333...9,357,765 JBrowse link
G HMOX1 heme oxygenase 1 treatment ISO CTD Direct Evidence: marker/mechanism|therapeutic RGD
CTD
PMID:18227147 PMID:22688006 PMID:22886620 PMID:29091898 RGD:10762620 RGD:15090820 NCBI chr19:18,144,466...18,157,944
Ensembl chr19:18,144,545...18,157,971
JBrowse link
G HPD 4-hydroxyphenylpyruvate dioxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 PMID:22872058 NCBI chr11:117,203,844...117,246,249
Ensembl chr11:117,203,307...117,224,038
JBrowse link
G HPRT1 hypoxanthine phosphoribosyltransferase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:109,629,674...109,671,409 JBrowse link
G HPX hemopexin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr 1:58,385,860...58,396,269
Ensembl chr 1:58,386,190...58,396,298
JBrowse link
G HRH2 histamine receptor H2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22926047 NCBI chr23:77,808,108...77,858,936
Ensembl chr23:77,807,998...77,841,467
JBrowse link
G HSPA5 heat shock protein family A (Hsp70) member 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:12,920,705...12,925,888
Ensembl chr12:12,920,710...12,927,431
JBrowse link
G HSPA8 heat shock protein family A (Hsp70) member 8 ISO protein:altered localization:liver (rat) RGD PMID:12376827 RGD:10059389 NCBI chr 1:114,447,348...114,452,693
Ensembl chr 1:114,446,544...114,451,562
JBrowse link
G ICAM1 intercellular adhesion molecule 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr 6:9,320,991...9,338,125
Ensembl chr 6:9,322,550...9,338,263
JBrowse link
G IDO2 indoleamine 2,3-dioxygenase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32289347 NCBI chr 8:37,951,810...38,027,689
Ensembl chr 8:37,959,078...38,027,632
JBrowse link
G IFNA2 interferon alpha 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1670585 NCBI chr12:58,468,018...58,469,825 JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:12153990 PMID:21245496 PMID:30013034 RGD:14975100 NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
JBrowse link
G IGF1 insulin like growth factor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:23639586 PMID:25226513 NCBI chr11:97,624,498...97,708,730
Ensembl chr11:97,631,189...97,707,308
JBrowse link
G IL11 interleukin 11 ISO CTD Direct Evidence: therapeutic CTD PMID:11421492 NCBI chr 6:47,967,245...47,972,557
Ensembl chr 6:47,967,680...47,971,316
JBrowse link
G IL12B interleukin 12B ISO CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr23:61,714,293...61,731,835 JBrowse link
G IL17A interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:19633216 PMID:24949944 NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
JBrowse link
G IL18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19164858 NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
JBrowse link
G IL1A interleukin 1 alpha ISO CTD Direct Evidence: therapeutic CTD PMID:8218930 NCBI chr14:15,789,710...15,801,938
Ensembl chr14:15,789,013...15,796,611
JBrowse link
G IL1B interleukin 1 beta treatment ISO CTD Direct Evidence: marker/mechanism|therapeutic RGD
CTD
PMID:19164858 PMID:23102243 PMID:28138970 PMID:29091898 PMID:29278859 More... RGD:13793380 RGD:14975281 RGD:15036799 RGD:15090820 RGD:7204421 NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
JBrowse link
G IL1R2 interleukin 1 receptor type 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr14:5,672,434...5,708,270
Ensembl chr14:5,673,163...5,708,372
JBrowse link
G IL22 interleukin 22 ISO CTD Direct Evidence: therapeutic CTD PMID:15122762 PMID:16212920 PMID:23375450 NCBI chr11:63,881,743...63,887,695
Ensembl chr11:63,882,093...63,886,761
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21094227 PMID:21735453 PMID:22107450 NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
JBrowse link
G IL6 interleukin 6 treatment ISO CTD Direct Evidence: therapeutic RGD
CTD
PMID:7532385 PMID:15763341 PMID:29091898 RGD:15090820 NCBI chr21:35,577,513...35,582,385
Ensembl chr21:35,577,939...35,582,237
JBrowse link
G IMMT inner membrane mitochondrial protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr14:20,949,586...21,013,535
Ensembl chr14:20,971,622...21,013,197
JBrowse link
G IRAK1 interleukin 1 receptor associated kinase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr  X:128,433,462...128,443,126
Ensembl chr  X:128,433,465...128,443,043
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr22:40,574,569...40,925,857
Ensembl chr22:40,574,374...40,926,842
JBrowse link
G JUND JunD proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:30515189 NCBI chr 6:16,754,553...16,756,458
Ensembl chr 6:16,755,247...16,756,290
JBrowse link
G KEAP1 kelch like ECH associated protein 1 ISO RGD PMID:18417483 RGD:6893370 NCBI chr 6:9,515,789...9,526,699
Ensembl chr 6:9,515,416...9,522,797
JBrowse link
G KITLG KIT ligand ISO CTD Direct Evidence: therapeutic CTD PMID:12594235 NCBI chr11:83,856,149...83,943,095
Ensembl chr11:83,856,157...83,943,083
JBrowse link
G KNG1 kininogen 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:30685357 NCBI chr15:81,002,287...81,027,893 JBrowse link
G KRT18 keratin 18 ISO mRNA, protein:increased expression:liver (mouse)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:17340120 PMID:19783637 PMID:33483742 RGD:18337498 NCBI chr11:49,073,733...49,081,706 JBrowse link
G KRT8 keratin 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:49,027,879...49,051,753 JBrowse link
G LAP3 leucine aminopeptidase 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr27:32,616,277...32,647,839
Ensembl chr27:32,616,273...32,647,706
JBrowse link
G LBP lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 2:25,375,364...25,407,181
Ensembl chr 2:25,374,755...25,406,839
JBrowse link
G LCAT lecithin-cholesterol acyltransferase ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr 5:59,495,936...59,500,530
Ensembl chr 5:59,497,115...59,500,448
JBrowse link
G LCN2 lipocalin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20362651 PMID:20623750 NCBI chr12:9,976,278...9,981,087
Ensembl chr12:9,976,614...9,980,870
JBrowse link
G LDLR low density lipoprotein receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:36108984 NCBI chr 6:10,062,204...10,091,780
Ensembl chr 6:10,062,790...10,091,377
JBrowse link
G LGALS3 galectin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22461450 NCBI chr24:32,311,343...32,328,335
Ensembl chr24:32,311,271...32,328,339
JBrowse link
G LIPC lipase C, hepatic type ISO mRNA:decreased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr26:24,946,843...25,109,338
Ensembl chr26:24,946,673...25,087,921
JBrowse link
G LOC103223058 glutathione hydrolase light chain 2 ISO RGD PMID:10934156 RGD:14701049 NCBI chr19:7,353,922...7,406,392 JBrowse link
G LOC103223491 peroxisome proliferator-activated receptor alpha ISO LPS-induced acute liver damage RGD PMID:21262334 RGD:5509941 NCBI chr19:28,614,892...28,709,272
Ensembl chr19:28,615,413...28,708,763
JBrowse link
G LOC103224275 glutathione S-transferase Mu 1 no_association ISO protein:increased expression:liver
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:17465707 PMID:18666253 PMID:21138988 PMID:24465778 PMID:24903797 More... RGD:14700937 RGD:14700941 RGD:14700959 RGD:14700970 RGD:7241599 NCBI chr20:23,854,969...23,861,634 JBrowse link
G LOC103230356 uncharacterized LOC103230356 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29515023 NCBI chr25:29,230,358...29,380,617
Ensembl chr25:29,233,558...29,379,922
JBrowse link
G LOC103231165 isocitrate dehydrogenase (NADP(+)) 2 severity ISO RGD PMID:31121248 RGD:14985250 NCBI chr29:8,633,429...8,650,744
Ensembl chr29:8,633,715...8,650,657
JBrowse link
G LOC103233689 thromboxane A2 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22206755 NCBI chr 6:3,354,358...3,365,779
Ensembl chr 6:3,355,314...3,359,761
JBrowse link
G LOC103238261 tubulin alpha-1A chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:45,419,046...45,423,574
Ensembl chr11:45,418,748...45,423,685
JBrowse link
G LOC103242911 nucleoside diphosphate kinase B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:42,176,690...42,182,041
Ensembl chr16:42,176,524...42,182,019
JBrowse link
G LOC103246766 cytochrome P450 3A8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28762043 NCBI chr28:13,297,566...13,330,023 JBrowse link
G LOC103247947 olfactory receptor 51E2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:62,172,573...62,180,085
Ensembl chr 1:62,177,553...62,178,515
JBrowse link
G LPL lipoprotein lipase treatment ISO RGD PMID:27071702 RGD:13794380 NCBI chr 8:18,009,049...18,038,315
Ensembl chr 8:18,009,093...18,038,598
JBrowse link
G LRAT lecithin retinol acyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:101,297,114...101,304,675
Ensembl chr 7:101,297,691...101,302,520
JBrowse link
G LTB4R leukotriene B4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:28487374 NCBI chr24:1,294,453...1,301,113
Ensembl chr24:1,298,729...1,299,790
JBrowse link
G LTF lactotransferrin ISO CTD Direct Evidence: therapeutic CTD PMID:16141546 NCBI chr22:7,867,332...7,896,403
Ensembl chr22:7,867,286...7,894,521
JBrowse link
G MAP1LC3B microtubule associated protein 1 light chain 3 beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:72,762,428...72,774,204
Ensembl chr 5:72,763,050...72,772,770
JBrowse link
G MAP3K5 mitogen-activated protein kinase kinase kinase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18700144 NCBI chr13:36,614,489...36,858,524
Ensembl chr13:36,615,633...36,858,601
JBrowse link
G MAT1A methionine adenosyltransferase 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 9:51,540,162...51,558,076
Ensembl chr 9:51,540,162...51,558,576
JBrowse link
G MCCC1 methylcrotonyl-CoA carboxylase subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:6,318,788...6,400,539
Ensembl chr15:6,318,791...6,401,849
JBrowse link
G MDH1 malate dehydrogenase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr14:43,406,502...43,425,525
Ensembl chr14:43,406,499...43,425,095
JBrowse link
G ME1 malic enzyme 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:7,889,211...8,112,793
Ensembl chr13:7,887,984...8,112,533
JBrowse link
G MED1 mediator complex subunit 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16109766 NCBI chr16:66,719,393...66,764,902
Ensembl chr16:66,719,423...66,762,896
JBrowse link
G MHC-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility ISO associated with tuberculosis;DNA:polymorphism: :HLA-DQA1*0102(human) RGD PMID:12359646 PMID:20639878 RGD:14398844 RGD:14401573 NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
JBrowse link
G MMP2 matrix metallopeptidase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15763341 NCBI chr 5:41,264,382...41,291,657
Ensembl chr 5:41,264,354...41,291,004
JBrowse link
G MMP9 matrix metallopeptidase 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 2:17,867,267...17,874,757
Ensembl chr 2:17,867,177...17,874,712
JBrowse link
G MST1 macrophage stimulating 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr22:11,078,662...11,083,885
Ensembl chr22:11,074,114...11,083,368
JBrowse link
G MST1R macrophage stimulating 1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:22575169 NCBI chr22:11,293,637...11,310,239
Ensembl chr22:11,293,263...11,309,980
JBrowse link
G MTHFR methylenetetrahydrofolate reductase treatment ISO associated with precursor lymphoblastic lymphoma/leukemia; DNA:SNP: :677C>T(human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:18551038 PMID:19648163 PMID:30545275 RGD:14696733 NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
JBrowse link
G MTPN myotrophin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr21:104,605,924...104,657,664
Ensembl chr21:104,605,592...104,657,866
JBrowse link
G MYD88 MYD88 innate immune signal transduction adaptor ameliorates ISO RGD PMID:17615358 RGD:150521532 NCBI chr15:1,276,804...1,281,811
Ensembl chr15:1,276,798...1,281,166
JBrowse link
G NAT2 N-acetyltransferase 2 treatment ISO CTD Direct Evidence: marker/mechanism
associated with Tuberculosis;DNA:haplotype: :
CTD
RGD
PMID:11915035 PMID:16799928 PMID:17950035 PMID:18023090 PMID:25693865 RGD:8552665 NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
JBrowse link
G NDUFS3 NADH:ubiquinone oxidoreductase core subunit S3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:17,735,040...17,740,508
Ensembl chr 1:17,733,645...17,745,677
JBrowse link
G NFATC4 nuclear factor of activated T cells 4 ISO CTD Direct Evidence: therapeutic CTD PMID:34192554 NCBI chr24:1,352,173...1,362,150
Ensembl chr24:1,352,291...1,362,680
JBrowse link
G NFE2L2 NFE2 like bZIP transcription factor 2 treatment ISO CTD Direct Evidence: therapeutic
induced by methotrexate (CHEBI:44185), treated by ferulic acid (CHEBI:17620)
CTD
RGD
PMID:18417483 PMID:22491424 PMID:22627062 PMID:24813929 PMID:26958860 More... RGD:15090820 RGD:21201280 RGD:21201283 RGD:21201305 RGD:21201308 RGD:6893370 NCBI chr10:62,789,647...62,825,651
Ensembl chr10:62,790,124...62,825,339
JBrowse link
G NFKB1 nuclear factor kappa B subunit 1 susceptibility
treatment
ISO associated with tuberculosis ;DNA:SNPs,haplotypes: 3'utr,5'utr: (rs78872571,rs4647992) (human) RGD PMID:29091898 PMID:31490979 RGD:15090820 RGD:40902984 NCBI chr 7:50,589,494...50,711,472
Ensembl chr 7:50,589,856...50,711,498
JBrowse link
G NFXL1 nuclear transcription factor, X-box binding like 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr27:2,333,158...2,401,008
Ensembl chr27:2,333,809...2,400,084
JBrowse link
G NOTCH1 notch receptor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:30394310 NCBI chr12:1,656,815...1,707,566
Ensembl chr12:1,656,918...1,709,585
JBrowse link
G NOX4 NADPH oxidase 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:80,470,418...80,642,513
Ensembl chr 1:80,470,826...80,642,722
JBrowse link
G NQO1 NAD(P)H quinone dehydrogenase 1 treatment ISO RGD PMID:28472605 PMID:28522909 PMID:29091898 RGD:13439737 RGD:13439739 RGD:15090820 NCBI chr 5:57,676,547...57,695,434
Ensembl chr 5:57,675,981...57,716,599
JBrowse link
G NR0B2 nuclear receptor subfamily 0 group B member 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29943110 NCBI chr20:105,850,328...105,853,076
Ensembl chr20:105,850,598...105,853,060
JBrowse link
G NR1D1 nuclear receptor subfamily 1 group D member 1 treatment ISO RGD PMID:24497272 RGD:10448995 NCBI chr16:66,078,990...66,086,927
Ensembl chr16:66,079,089...66,090,685
JBrowse link
G NR1H3 nuclear receptor subfamily 1 group H member 3 ISO CTD Direct Evidence: therapeutic CTD PMID:17256725 NCBI chr 1:18,041,495...18,061,196
Ensembl chr 1:18,041,830...18,051,501
JBrowse link
G NR1H4 nuclear receptor subfamily 1 group H member 4 severity
treatment
ISO CTD Direct Evidence: marker/mechanism
protein:decreased expression:liver (rat)
mRNA:decreased expression:liver (rat)
CTD
RGD
PMID:12875239 PMID:20573685 PMID:22711662 PMID:28827769 PMID:29091898 More... RGD:14701035 RGD:14701036 RGD:15042870 RGD:15045609 RGD:15090820 NCBI chr11:95,792,428...95,877,989
Ensembl chr11:95,792,996...95,878,293
JBrowse link
G NR1I2 nuclear receptor subfamily 1 group I member 2 susceptibility ISO associated with tuberculosis ;DNA:SNP,haplotypes:promoter: (rs3814055) (human)
CTD Direct Evidence: marker/mechanism|therapeutic
RGD
CTD
PMID:19797606 PMID:28058446 PMID:31490979 RGD:40902984 NCBI chr22:61,005,404...61,043,016
Ensembl chr22:61,006,667...61,040,832
JBrowse link
G NR1I3 nuclear receptor subfamily 1 group I member 3 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:14742670 PMID:25656644 PMID:28058446 NCBI chr20:2,724,843...2,752,999
Ensembl chr20:2,744,908...2,756,658
JBrowse link
G NR2F2 nuclear receptor subfamily 2 group F member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr29:14,889,526...14,901,848
Ensembl chr29:14,891,737...14,903,813
JBrowse link
G NREP neuronal regeneration related protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr23:15,065,565...15,314,999
Ensembl chr23:15,064,445...15,093,992
JBrowse link
G NTN1 netrin 1 ISO CTD Direct Evidence: therapeutic CTD PMID:35292334 NCBI chr16:8,359,682...8,603,231
Ensembl chr16:8,379,129...8,603,223
JBrowse link
G NUS1 NUS1 dehydrodolichyl diphosphate synthase subunit ISO CTD Direct Evidence: therapeutic CTD PMID:33812996 NCBI chr13:56,115,581...56,147,918
Ensembl chr13:56,113,428...56,147,982
JBrowse link
G OCIAD1 OCIA domain containing 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr27:1,394,512...1,424,286
Ensembl chr27:1,391,852...1,424,270
JBrowse link
G OGDH oxoglutarate dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr21:13,975,825...14,070,216
Ensembl chr21:13,973,845...14,070,731
JBrowse link
G P4HB prolyl 4-hydroxylase subunit beta ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr16:73,718,743...73,733,488
Ensembl chr16:73,718,656...73,733,892
JBrowse link
G PAH phenylalanine hydroxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:98,065,869...98,140,011
Ensembl chr11:98,063,199...98,139,285
JBrowse link
G PAN2 poly(A) specific ribonuclease subunit PAN2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr11:52,273,867...52,290,514
Ensembl chr11:52,274,540...52,289,410
JBrowse link
G PANX1 pannexin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:29246445 NCBI chr 1:85,356,507...85,413,146
Ensembl chr 1:85,356,610...85,409,275
JBrowse link
G PARK7 Parkinsonism associated deglycase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:123,776,084...123,808,031
Ensembl chr20:123,776,297...123,798,434
JBrowse link
G PC pyruvate carboxylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:7,310,738...7,418,357
Ensembl chr 1:7,357,246...7,417,998
JBrowse link
G PCOLCE procollagen C-endopeptidase enhancer ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr28:12,604,552...12,610,814
Ensembl chr28:12,604,526...12,610,814
JBrowse link
G PCYT1A phosphate cytidylyltransferase 1A, choline ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr15:90,905,691...90,944,485 JBrowse link
G PDK4 pyruvate dehydrogenase kinase 4 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:21182459 PMID:31809757 NCBI chr21:53,445,607...53,458,729
Ensembl chr21:53,445,457...53,460,776
JBrowse link
G PDLIM5 PDZ and LIM domain 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 7:42,702,175...42,912,859
Ensembl chr 7:42,819,454...42,908,137
JBrowse link
G PEX11A peroxisomal biogenesis factor 11 alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr29:8,220,082...8,229,448
Ensembl chr29:8,221,920...8,229,243
JBrowse link
G PGM1 phosphoglucomutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:69,391,487...69,495,156
Ensembl chr20:69,428,996...69,466,191
JBrowse link
G PLAT plasminogen activator, tissue type ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr 8:40,164,391...40,196,627
Ensembl chr 8:40,163,891...40,196,555
JBrowse link
G PLG plasminogen ISO CTD Direct Evidence: marker/mechanism CTD PMID:22507835 NCBI chr13:88,266,054...88,321,596
Ensembl chr13:88,268,198...88,322,644
JBrowse link
G PLS3 plastin 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249
G PNP purine nucleoside phosphorylase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr29:20,992,892...21,001,400
Ensembl chr29:20,993,280...21,001,606
JBrowse link
G PNRC1 proline rich nuclear receptor coactivator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr13:13,846,691...13,850,785
Ensembl chr13:13,846,864...13,850,141
JBrowse link
G POLG DNA polymerase gamma, catalytic subunit susceptibility
no_association
ISO DNA:missense mutation:cds:p.W748S, p.E1143G (2243G>C, 3428A>G) (human)
DNA:missense mutations:cds:p.Q1236H, p.E1143G (33708G>T, 3428A>G) (human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:18208989 PMID:20138553 PMID:25065347 PMID:30255931 RGD:15039297 RGD:15039302 NCBI chr29:7,864,319...7,881,577
Ensembl chr29:7,863,277...7,882,068
JBrowse link
G POLR2G RNA polymerase II subunit G ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 1:11,140,897...11,150,879
Ensembl chr 1:11,140,867...11,150,882
JBrowse link
G PON1 paraoxonase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr21:53,713,434...53,739,658
Ensembl chr21:53,714,012...53,739,875
JBrowse link
G PPARA peroxisome proliferator activated receptor alpha ISO CTD Direct Evidence: marker/mechanism CTD PMID:24385052
G PPARG peroxisome proliferator activated receptor gamma ISO mRNA, protein:decreased expression:liver RGD PMID:26599535 RGD:11554658 NCBI chr22:48,262,743...48,407,415
Ensembl chr22:48,275,600...48,407,418
JBrowse link
G PPTC7 protein phosphatase targeting COQ7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr11:105,774,912...105,823,882
Ensembl chr11:105,778,596...105,823,836
JBrowse link
G PRKAA1 protein kinase AMP-activated catalytic subunit alpha 1 treatment ISO RGD PMID:29091898 RGD:15090820 NCBI chr 4:39,516,307...39,553,627 JBrowse link
G PRKCD protein kinase C delta ISO CTD Direct Evidence: therapeutic CTD PMID:30393195 NCBI chr22:14,561,401...14,592,877
Ensembl chr22:14,565,282...14,592,873
JBrowse link
G PRKDC protein kinase, DNA-activated, catalytic subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:21224054 NCBI chr 8:43,915,226...44,119,547
Ensembl chr 8:43,914,636...44,119,541
JBrowse link
G PTF1A pancreas associated transcription factor 1a ISO CTD Direct Evidence: therapeutic CTD PMID:21182459 NCBI chr 9:22,944,122...22,965,905
Ensembl chr 9:22,964,164...22,965,565
JBrowse link
G PTGS2 prostaglandin-endoperoxide synthase 2 treatment ISO CTD Direct Evidence: therapeutic RGD
CTD
PMID:11743745 PMID:29091898 RGD:15090820 NCBI chr25:42,733,535...42,742,463
Ensembl chr25:42,734,771...42,742,429
JBrowse link
G PUM1 pumilio RNA binding family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr20:101,773,819...101,910,433
Ensembl chr20:101,773,960...101,910,519
JBrowse link
G PYGL glycogen phosphorylase L ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:serum (rat)
CTD
RGD
PMID:25231249 PMID:25336395 RGD:21079733 NCBI chr24:27,987,676...28,030,919
Ensembl chr24:27,987,649...28,030,869
JBrowse link
G PZP PZP alpha-2-macroglobulin like ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr11:8,963,883...9,023,148
Ensembl chr11:8,963,461...9,014,957
JBrowse link
G RASA1 RAS p21 protein activator 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr 4:81,249,851...81,371,486
Ensembl chr 4:81,249,805...81,370,453
JBrowse link
G RBP1 retinol binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr15:51,011,664...51,033,963 JBrowse link
G RDH13 retinol dehydrogenase 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27865848 NCBI chr 6:47,634,909...47,652,829
Ensembl chr 6:47,636,094...47,652,772
JBrowse link
G REEP5 receptor accessory protein 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr23:16,165,233...16,210,082
Ensembl chr23:16,167,557...16,210,050
JBrowse link
G RGN regucalcin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:44,282,825...44,299,027
Ensembl chr  X:44,285,601...44,299,258
JBrowse link
G RIPK3 receptor interacting serine/threonine kinase 3 ISO CTD Direct Evidence: therapeutic
protein:increased expression:liver (mouse)
CTD
RGD
PMID:26769846 PMID:28205631 RGD:127229945 NCBI chr24:1,318,265...1,322,610
Ensembl chr24:1,318,216...1,322,462
JBrowse link
G S100A11 S100 calcium binding protein A11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:11,613,171...11,617,711 JBrowse link
G SCARB1 scavenger receptor class B member 1 ISO mRNA:increased expression:liver (rat) RGD PMID:28959666 RGD:401794432 NCBI chr11:120,134,485...120,223,512
Ensembl chr11:120,134,874...120,216,904
JBrowse link
G SELENBP1 selenium binding protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr20:12,321,445...12,330,495
Ensembl chr20:12,321,292...12,330,746
JBrowse link
G SEMA3A semaphorin 3A ISO CTD Direct Evidence: therapeutic CTD PMID:33290778 NCBI chr21:64,723,860...64,942,705
Ensembl chr21:64,784,039...64,939,682
JBrowse link
G SEMA4A semaphorin 4A ISO CTD Direct Evidence: marker/mechanism CTD PMID:33290778 NCBI chr20:7,684,107...7,716,866
Ensembl chr20:7,683,994...7,708,741
JBrowse link
G SENP2 SUMO specific peptidase 2 ISO CTD Direct Evidence: therapeutic CTD PMID:29535048 NCBI chr15:3,805,916...3,853,529 JBrowse link
G SERPINA1 serpin family A member 1 susceptibility ISO protein:decreased expression:plasma
DNA:missense mutation:cds:p.E264V(human)
RGD PMID:11140575 PMID:20170533 RGD:14695048 RGD:1643168 NCBI chr24:72,158,521...72,171,139
Ensembl chr24:72,156,784...72,163,500
JBrowse link
G SERPINA6 serpin family A member 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr24:72,079,084...72,098,549
Ensembl chr24:72,077,274...72,098,154
JBrowse link
G SERPINE1 serpin family E member 1 treatment ISO associated with precursor lymphoblastic lymphoma/leukemia;DNA:SNPs: :DNA:SNPs: :677C>T, 1298A>C(human) RGD PMID:23183238 RGD:14696750 NCBI chr28:12,047,520...12,060,662
Ensembl chr28:12,047,529...12,060,202
JBrowse link
G SERPING1 serpin family G member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:15,617,122...15,634,540
Ensembl chr 1:15,616,674...15,633,855
JBrowse link
G SESN2 sestrin 2 ISO CTD Direct Evidence: therapeutic CTD PMID:28209544 NCBI chr20:104,521,131...104,544,161
Ensembl chr20:104,521,132...104,544,001
JBrowse link
G SGF29 SAGA complex associated factor 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 5:26,399,760...26,439,616
Ensembl chr 5:26,399,677...26,439,530
JBrowse link
G SHC1 SHC adaptor protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 PMID:32659284 NCBI chr20:8,854,189...8,866,406
Ensembl chr20:8,858,458...8,866,610
JBrowse link
G SLC10A1 solute carrier family 10 member 1 ISO mRNA:decreased expression:liver (rat) RGD PMID:28827769 RGD:15045609 NCBI chr24:47,018,237...47,034,360
Ensembl chr24:47,017,414...47,033,940
JBrowse link
G SLC10A7 solute carrier family 10 member 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:92,798,344...93,052,737 JBrowse link
G SLC13A4 solute carrier family 13 member 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr21:104,359,577...104,407,905
Ensembl chr21:104,363,792...104,405,562
JBrowse link
G SLC22A8 solute carrier family 22 member 8 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:10,885,895...10,909,739
Ensembl chr 1:10,886,690...10,910,546
JBrowse link
G SLC25A29 solute carrier family 25 member 29 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr24:78,251,571...78,266,550
Ensembl chr24:78,250,796...78,266,490
JBrowse link
G SLC7A5 solute carrier family 7 member 5 treatment ISO RGD PMID:9200186 RGD:151357001 NCBI chr 5:73,229,953...73,269,801
Ensembl chr 5:73,229,951...73,269,754
JBrowse link
G SLCO1B1 solute carrier organic anion transporter family member 1B1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:32259555 NCBI chr11:20,992,353...21,091,761
Ensembl chr11:21,001,655...21,093,278
JBrowse link
G SLPI secretory leukocyte peptidase inhibitor ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 2:18,579,549...18,581,897
Ensembl chr 2:18,579,515...18,582,076
JBrowse link
G SNX18 sorting nexin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr 4:50,782,842...50,810,220
Ensembl chr 4:50,782,929...50,811,253
JBrowse link
G SOD1 superoxide dismutase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 PMID:27349771 NCBI chr 2:60,461,219...60,472,999 JBrowse link
G SOD2 superoxide dismutase 2 susceptibility
severity
treatment
ISO DNA:SNP:cds:p.Val16Ala(human)
associated with acute lymphoblastic leukemia;DNA:SNP: :(rs4880)(human)
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:19332662 PMID:19647030 PMID:20578157 PMID:25226513 PMID:27019981 RGD:11060605 RGD:26923957 RGD:26923959 RGD:26923961 NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
JBrowse link
G SOD3 superoxide dismutase 3 ISO CTD Direct Evidence: therapeutic CTD PMID:11529661 NCBI chr27:25,554,474...25,559,873
Ensembl chr27:25,555,082...25,555,804
JBrowse link
G SORD sorbitol dehydrogenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:12763371 NCBI chr26:38,129,236...38,173,867
Ensembl chr26:38,126,911...38,155,381
JBrowse link
G SORL1 sortilin related receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 1:112,877,052...113,062,167
Ensembl chr 1:112,877,151...113,058,050
JBrowse link
G SPP1 secreted phosphoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20623750 NCBI chr 7:36,337,165...36,344,927
Ensembl chr 7:36,338,386...36,344,407
JBrowse link
G SRP72 signal recognition particle 72 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr 7:12,127,817...12,162,992
Ensembl chr 7:12,126,607...12,162,951
JBrowse link
G STAT4 signal transducer and activator of transcription 4 severity ISO protein:increased phosphorylation:liver, inflammatory cell (mouse)
mRNA:increased expression:liver, macrophage (mouse)
RGD PMID:23876342 PMID:24731448 RGD:25671417 RGD:25671422 NCBI chr10:76,553,626...76,708,540
Ensembl chr10:76,553,606...76,674,928
JBrowse link
G STING1 stimulator of interferon response cGAMP interactor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:36520315 NCBI chr23:42,153,576...42,160,903
Ensembl chr23:42,153,026...42,160,907
JBrowse link
G SULT1C3 sulfotransferase family 1C member 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr14:11,621,851...11,638,719
Ensembl chr14:11,622,043...11,636,652
JBrowse link
G SULT1E1 sulfotransferase family 1E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 7:18,313,510...18,330,768
Ensembl chr 7:18,313,238...18,330,741
JBrowse link
G SULT2B1 sulfotransferase family 2B member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:27052460 NCBI chr 6:41,809,654...41,852,685
Ensembl chr 6:41,810,049...41,852,681
JBrowse link
G SUOX sulfite oxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:51,935,809...51,943,090
Ensembl chr11:51,939,809...51,942,603
JBrowse link
G TAGLN2 transgelin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr20:4,024,948...4,032,361
Ensembl chr20:4,024,775...4,032,526
JBrowse link
G TALDO1 transaldolase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19436114 NCBI chr 1:553,475...569,935
Ensembl chr 1:553,458...573,546
JBrowse link
G TCTN1 tectonic family member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17984051 NCBI chr11:105,855,138...105,898,764
Ensembl chr11:105,855,288...105,891,093
JBrowse link
G TF transferrin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr15:56,586,311...56,618,304
Ensembl chr15:56,586,104...56,618,149
JBrowse link
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:27516150 RGD:14995464 NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
JBrowse link
G TGFBR1 transforming growth factor beta receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:28560358 NCBI chr12:40,272,507...40,321,740
Ensembl chr12:40,276,916...40,297,372
JBrowse link
G THBS1 thrombospondin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:35357534 NCBI chr26:43,410,693...43,427,816
Ensembl chr26:43,410,580...43,427,812
JBrowse link
G THPO thrombopoietin ISO CTD Direct Evidence: therapeutic CTD PMID:33122006 NCBI chr15:5,040,684...5,048,387 JBrowse link
G TLR4 toll like receptor 4 disease_progression ISO RGD PMID:17504260 RGD:14697733 NCBI chr12:21,873,762...21,885,562
Ensembl chr12:21,871,773...21,885,515
JBrowse link
G TLR5 toll like receptor 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:30508503 NCBI chr25:6,418,895...6,440,433
Ensembl chr25:6,437,638...6,440,211
JBrowse link
G TMED7 transmembrane p24 trafficking protein 7 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr23:18,864,021...18,875,089
Ensembl chr23:18,866,758...18,874,975
JBrowse link
G TMEM117 transmembrane protein 117 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr11:40,049,469...40,590,373 JBrowse link
G TMEM164 transmembrane protein 164 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr  X:97,833,179...98,007,700
Ensembl chr  X:97,833,496...98,003,343
JBrowse link
G TMEM38B transmembrane protein 38B ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr12:33,759,311...33,840,357
Ensembl chr12:33,759,157...33,840,009
JBrowse link
G TNF tumor necrosis factor treatment
severity
ISO CTD Direct Evidence: marker/mechanism|therapeutic
protein:increased expression:serum (rat)
RGD
CTD
PMID:7532385 PMID:9309314 PMID:9696492 PMID:10801287 PMID:10801288 More... RGD:10450531 RGD:14696804 RGD:14975281 RGD:14995429 RGD:14995432 RGD:14995435 RGD:14995437 RGD:14995485 RGD:15036799 RGD:15090820
G TRPM2 transient receptor potential cation channel subfamily M member 2 ISO RGD PMID:24569808 RGD:9999438 NCBI chr 2:88,082,391...88,170,340
Ensembl chr 2:88,087,448...88,170,344
JBrowse link
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16099942 NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
JBrowse link
G TUBB4B tubulin beta 4B class IVb ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr12:945,643...948,087
Ensembl chr12:945,459...948,065
JBrowse link
G UBA5 ubiquitin like modifier activating enzyme 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:26881866 NCBI chr15:57,596,490...57,613,103
Ensembl chr15:57,592,728...57,612,928
JBrowse link
G UNC93B1 unc-93 homolog B1, TLR signaling regulator ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 1:6,537,198...6,549,457
Ensembl chr 1:6,537,273...6,549,450
JBrowse link
G USP5 ubiquitin specific peptidase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr11:6,885,401...6,899,983
Ensembl chr11:6,885,311...6,898,442
JBrowse link
G VEGFA vascular endothelial growth factor A treatment ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:17784864 PMID:25231249 RGD:15003197 NCBI chr17:28,377,959...28,394,508 JBrowse link
G VIM vimentin ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr 9:17,183,466...17,191,771
Ensembl chr 9:17,183,388...17,191,829
JBrowse link
G VWF von Willebrand factor ISO CTD Direct Evidence: marker/mechanism
protein:increased expression:liver:
CTD
RGD
PMID:7531171 PMID:28527913 RGD:11079232 NCBI chr11:5,994,499...6,176,949
Ensembl chr11:5,994,039...6,162,260
JBrowse link
G WASL WASP like actin nucleation promoting factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr21:92,480,392...92,546,725
Ensembl chr21:92,482,918...92,546,481
JBrowse link
G XRCC1 X-ray repair cross complementing 1 susceptibility ISO DNA:haploinsufficiency: : (mouse) RGD PMID:21737425 RGD:15036796 NCBI chr 6:37,062,149...37,095,138
Ensembl chr 6:37,060,439...37,095,094
JBrowse link
G XYLB xylulokinase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25231249 NCBI chr15:1,003,809...1,070,385
Ensembl chr15:1,005,340...1,069,275
JBrowse link
G ZDHHC23 zinc finger DHHC-type palmitoyltransferase 23 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25226513 NCBI chr22:66,905,388...66,917,104
Ensembl chr22:66,901,395...66,915,702
JBrowse link
drug allergy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20216337 NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
JBrowse link
G ADORA1 adenosine A1 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr25:26,180,898...26,221,424
Ensembl chr25:26,182,446...26,220,776
JBrowse link
G ADORA2A adenosine A2a receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:19019667 NCBI chr19:7,691,678...7,706,781
Ensembl chr19:7,691,536...7,706,926
JBrowse link
G CCL11 C-C motif chemokine ligand 11 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr16:27,792,699...27,796,437
Ensembl chr16:27,794,033...27,796,460
JBrowse link
G CCL24 C-C motif chemokine ligand 24 ISO CTD Direct Evidence: marker/mechanism CTD PMID:14616128 NCBI chr28:10,067,482...10,069,992
Ensembl chr28:10,066,664...10,069,695
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 9:88,082,124...88,125,390 JBrowse link
G CYSLTR1 cysteinyl leukotriene receptor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16630147
G CYSLTR2 cysteinyl leukotriene receptor 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15970796 NCBI chr 3:26,578,248...26,624,364 JBrowse link
G FASLG Fas ligand ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr25:56,488,572...56,496,469
Ensembl chr25:56,489,417...56,496,251
JBrowse link
G FCER1A Fc fragment of IgE receptor Ia ISO CTD Direct Evidence: marker/mechanism CTD PMID:17125826 PMID:20485159 NCBI chr20:4,635,316...4,640,787
Ensembl chr20:4,635,328...4,640,590
JBrowse link
G FCER1G Fc fragment of IgE receptor Ig ISO CTD Direct Evidence: marker/mechanism CTD PMID:18534082 PMID:18595682 NCBI chr20:2,763,412...2,767,774
Ensembl chr20:2,763,417...2,767,248
JBrowse link
G GSTP1 glutathione S-transferase pi 1 susceptibility ISO CTD Direct Evidence: marker/mechanism
associated with Acquired Immunodeficiency Syndrome;DNA:polymorphism:exon:A>G313 (rs1695) (human)
CTD
RGD
PMID:16297214 PMID:20485159 RGD:5490995 NCBI chr 1:6,676,897...6,679,936 JBrowse link
G GZMB granzyme B ISO CTD Direct Evidence: marker/mechanism CTD PMID:19706026 NCBI chr24:1,574,452...1,577,861
Ensembl chr24:1,574,453...1,577,798
JBrowse link
G HNMT histamine N-methyltransferase ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr10:22,188,151...22,238,665
Ensembl chr10:22,188,110...22,238,671
JBrowse link
G IL10 interleukin 10 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19222424 PMID:20485159 NCBI chr25:22,590,389...22,595,877
Ensembl chr25:22,590,962...22,594,836
JBrowse link
G IL13 interleukin 13 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr23:35,475,762...35,479,419
Ensembl chr23:35,476,490...35,478,869
JBrowse link
G IL2 interleukin 2 ISO RGD PMID:1549655 RGD:8662975 NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:15867870 PMID:20485159 NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
JBrowse link
G IL4R interleukin 4 receptor ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 NCBI chr 5:25,019,638...25,069,732
Ensembl chr 5:25,046,701...25,070,015
JBrowse link
G LOC103221744 heat shock 70 kDa protein 1-like ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr17:40,206,365...40,211,996
Ensembl chr17:40,209,754...40,211,676
JBrowse link
G LOC103221745 heat shock 70 kDa protein 1A ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538175 NCBI chr17:40,203,647...40,206,028
Ensembl chr17:40,203,936...40,205,858
JBrowse link
G LOC103224275 glutathione S-transferase Mu 1 susceptibility ISO CTD Direct Evidence: marker/mechanism
DNA:deletion: :
CTD
RGD
PMID:11007341 PMID:20485159 RGD:5491000 NCBI chr20:23,854,969...23,861,634 JBrowse link
G LTC4S leukotriene C4 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16433794 NCBI chr23:81,523,784...81,526,297
Ensembl chr23:81,523,775...81,526,179
JBrowse link
G MLN motilin ISO CTD Direct Evidence: marker/mechanism CTD PMID:16538176 NCBI chr17:38,275,784...38,286,662 JBrowse link
G MS4A2 membrane spanning 4-domains A2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16839402 PMID:18534082 PMID:20485159 NCBI chr 1:13,657,842...13,666,314
Ensembl chr 1:13,654,696...13,665,925
JBrowse link
G NAT2 N-acetyltransferase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20485159 PMID:20602614 PMID:21572414 NCBI chr 8:16,451,144...16,494,961
Ensembl chr 8:16,493,749...16,494,621
JBrowse link
G NLRP3 NLR family pyrin domain containing 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19767079 NCBI chr25:84,431,436...84,463,387
Ensembl chr25:84,434,527...84,463,249
JBrowse link
G POSTN periostin ISO CTD Direct Evidence: marker/mechanism CTD PMID:18391768 NCBI chr 3:16,060,013...16,095,867
Ensembl chr 3:16,059,965...16,095,791
JBrowse link
G PTGER3 prostaglandin E receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20587336 NCBI chr20:62,093,830...62,293,360
Ensembl chr20:62,095,458...62,174,959
JBrowse link
G PTGS1 prostaglandin-endoperoxide synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:17508966 NCBI chr12:17,195,403...17,218,450
Ensembl chr12:17,192,628...17,218,315
JBrowse link
G TAC1 tachykinin precursor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21233199 NCBI chr21:51,339,085...51,347,561
Ensembl chr21:51,339,095...51,347,550
JBrowse link
G TBXAS1 thromboxane A synthase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21449675 NCBI chr21:108,584,458...108,779,357
Ensembl chr21:108,628,570...108,779,163
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:11294926 PMID:20485159
G TNFRSF10A TNF receptor superfamily member 10a ISO CTD Direct Evidence: marker/mechanism CTD PMID:19652058 NCBI chr 8:21,318,987...21,351,641
Ensembl chr 8:21,315,149...21,351,673
JBrowse link
Drug Eruptions term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr 9:41,085,257...41,145,760
Ensembl chr 9:41,085,361...41,145,331
JBrowse link
G APOA1 apolipoprotein A1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 1:108,201,967...108,203,902
Ensembl chr 1:108,201,439...108,203,609
JBrowse link
G APOC2 apolipoprotein C2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 6:38,406,829...38,411,239
Ensembl chr 6:38,409,641...38,410,927
JBrowse link
G APOC3 apolipoprotein C3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr 1:108,196,283...108,199,274
Ensembl chr 1:108,196,939...108,199,342
JBrowse link
G BDNF brain derived neurotrophic factor ISO mRNA:increased expression:lymph node, ear: RGD PMID:19904815 RGD:8657071 NCBI chr 1:37,386,825...37,451,380
Ensembl chr 1:37,449,593...37,450,336
JBrowse link
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
JBrowse link
G CYP2C19 cytochrome P450 family 2 subfamily C member 19 treatment
susceptibility
ISO associated with tuberculosis; DNA.polymorphism, haplotype:cds:p.W212X (human)
DNA:SNP: :Rs4244285(human)
RGD PMID:20941486 PMID:23551241 RGD:11352742 RGD:124713543 NCBI chr 9:87,981,300...88,025,007 JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
JBrowse link
G FCER1A Fc fragment of IgE receptor Ia ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr20:4,635,316...4,640,787
Ensembl chr20:4,635,328...4,640,590
JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
JBrowse link
G IL17A interleukin 17A ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr17:20,314,082...20,319,917
Ensembl chr17:20,315,773...20,318,785
JBrowse link
G IL18 interleukin 18 ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr 1:103,485,868...103,511,632
Ensembl chr 1:103,482,083...103,510,150
JBrowse link
G IL2 interleukin 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 7:69,729,635...69,736,279
Ensembl chr 7:69,730,282...69,734,969
JBrowse link
G IL4 interleukin 4 ISO CTD Direct Evidence: marker/mechanism CTD PMID:19351467 NCBI chr23:35,492,158...35,501,349
Ensembl chr23:35,492,939...35,501,258
JBrowse link
G KNG1 kininogen 1 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:1371395 PMID:3034372 NCBI chr15:81,002,287...81,027,893 JBrowse link
G MHC-DPB1 major histocompatibility complex, class II, DP beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:16502481 NCBI chr17:38,996,329...39,007,097 JBrowse link
G MHC-DQA1 major histocompatibility complex, class II, DQ alpha 1 susceptibility ISO DNA:polymorphisms:exon: RGD PMID:16836882 RGD:8547665 NCBI chr17:39,422,445...39,428,777
Ensembl chr17:39,420,134...39,428,871
JBrowse link
G MPO myeloperoxidase ISO CTD Direct Evidence: marker/mechanism CTD PMID:18204966 NCBI chr16:35,120,194...35,130,851
Ensembl chr16:35,120,581...35,130,671
JBrowse link
G MTHFR methylenetetrahydrofolate reductase ISO CTD Direct Evidence: marker/mechanism CTD PMID:14723717 NCBI chr20:119,987,667...120,003,611
Ensembl chr20:119,990,133...120,002,950
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805 NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
JBrowse link
G TAC1 tachykinin precursor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:1371395 NCBI chr21:51,339,085...51,347,561
Ensembl chr21:51,339,095...51,347,550
JBrowse link
G TNF tumor necrosis factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:31150805
G TTR transthyretin ISO CTD Direct Evidence: marker/mechanism CTD PMID:21055120 NCBI chr18:49,124,302...49,131,495
Ensembl chr18:49,124,121...49,131,399
JBrowse link
Drug Hypersensitivity Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C1QA complement C1q A chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:110,024,847...110,027,868 JBrowse link
G C1QB complement C1q B chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:110,003,036...110,011,317
Ensembl chr20:110,002,864...110,011,316
JBrowse link
G C1QC complement C1q C chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:110,016,355...110,021,123
Ensembl chr20:110,016,362...110,020,854
JBrowse link
G CRP C-reactive protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
JBrowse link
G IL1B interleukin 1 beta ISO DNA:SNP:promoter:-511C>T (rs 16944) (human) RGD PMID:23461376 RGD:11051970 NCBI chr14:15,844,628...15,852,652
Ensembl chr14:15,844,672...15,850,729
JBrowse link
G IL1RN interleukin 1 receptor antagonist ISO DNA:SNP:intron:rs2234663 (human) RGD PMID:23461376 RGD:11051970 NCBI chr14:16,136,667...16,152,451
Ensembl chr14:16,146,333...16,151,326
JBrowse link
G LBP lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 2:25,375,364...25,407,181
Ensembl chr 2:25,374,755...25,406,839
JBrowse link
G LOC103218970 alpha-1-acid glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr12:25,257,002...25,261,255
Ensembl chr12:25,256,969...25,260,446
JBrowse link
G LOC103221744 heat shock 70 kDa protein 1-like ISO DNA:polymorphism, haplotype: :p.M493T (human) RGD PMID:15024131 RGD:8662461 NCBI chr17:40,206,365...40,211,996
Ensembl chr17:40,209,754...40,211,676
JBrowse link
G LPA lipoprotein(a) ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr13:88,077,041...88,337,256 JBrowse link
G LRG1 leucine rich alpha-2-glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:4,272,231...4,275,060
Ensembl chr 6:4,272,214...4,274,460
JBrowse link
G VWF von Willebrand factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr11:5,994,499...6,176,949
Ensembl chr11:5,994,039...6,162,260
JBrowse link
Drug-Induced Dyskinesia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABAT 4-aminobutyrate aminotransferase ISO RGD PMID:6445277 PMID:7740056 RGD:10047091 RGD:1598524 NCBI chr 5:8,274,310...8,380,973
Ensembl chr 5:8,315,952...8,379,549
JBrowse link
G CACNA1D calcium voltage-gated channel subunit alpha1 D ISO RGD PMID:18947822 RGD:6906919 NCBI chr22:14,868,459...15,195,002
Ensembl chr22:15,027,565...15,197,101
JBrowse link
G CAT catalase ISO CTD Direct Evidence: marker/mechanism CTD PMID:19109989 NCBI chr 1:30,792,533...30,828,920
Ensembl chr 1:30,792,399...30,829,592
JBrowse link
G CCK cholecystokinin ISO CTD Direct Evidence: therapeutic CTD PMID:2320253 NCBI chr22:3,698,192...3,705,443
Ensembl chr22:3,698,173...3,704,956
JBrowse link
G COMT catechol-O-methyltransferase ISO RGD PMID:16437585 RGD:2289781 NCBI chr19:5,775,829...5,803,260
Ensembl chr19:5,773,225...5,785,422
JBrowse link
G CYP2D6 cytochrome P450 family 2 subfamily D member 6 ISO RGD PMID:12629505 RGD:1358549 NCBI chr19:24,667,207...24,672,580
Ensembl chr19:24,667,282...24,671,513
JBrowse link
G DBN1 drebrin 1 ISO levodopainduced; protein:increased expression:striatum: RGD PMID:23241013 RGD:10398811 NCBI chr23:79,468,010...79,484,603
Ensembl chr23:79,467,647...79,484,592
JBrowse link
G DDC dopa decarboxylase ISO associated with Parkinson Disease; protein:decreased expression:striatum (rat) RGD PMID:20232137 RGD:5128860 NCBI chr21:8,235,396...8,343,086
Ensembl chr21:8,235,343...8,343,361
JBrowse link
G DRD1 dopamine receptor D1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:7845605 PMID:10858612 PMID:16982285 PMID:19520364 NCBI chr23:77,587,340...77,591,434 JBrowse link
G DRD2 dopamine receptor D2 ISO CTD Direct Evidence: marker/mechanism CTD
RGD
PMID:7845605 PMID:10534246 PMID:14629710 PMID:18707801 RGD:2311579 NCBI chr 1:104,774,632...104,843,417
Ensembl chr 1:104,774,180...104,842,736
JBrowse link
G DRD3 dopamine receptor D3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:20945430 NCBI chr22:66,683,987...66,737,645
Ensembl chr22:66,691,177...66,736,690
JBrowse link
G EGR1 early growth response 1 ISO RGD PMID:22153973 RGD:10395307 NCBI chr23:41,139,636...41,143,598
Ensembl chr23:41,140,065...41,142,374
JBrowse link
G FOSB FosB proto-oncogene, AP-1 transcription factor subunit ISO CTD Direct Evidence: marker/mechanism CTD PMID:17219962 NCBI chr 6:38,916,039...38,924,129 JBrowse link
G GAD1 glutamate decarboxylase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:9767399 NCBI chr10:56,351,495...56,396,476
Ensembl chr10:56,353,253...56,396,524
JBrowse link
G GCH1 GTP cyclohydrolase 1 ISO CTD Direct Evidence: therapeutic CTD PMID:15659429 NCBI chr24:32,029,997...32,079,656
Ensembl chr24:32,027,648...32,079,490
JBrowse link
G GDNF glial cell derived neurotrophic factor ISO CTD Direct Evidence: therapeutic CTD PMID:11168568 NCBI chr 4:36,662,033...36,691,761
Ensembl chr 4:36,665,009...36,684,257
JBrowse link
G GLUL glutamate-ammonia ligase ISO RGD PMID:6445277 RGD:10047091 NCBI chr25:46,988,853...46,998,112
Ensembl chr25:46,989,205...47,000,555
JBrowse link
G GRK6 G protein-coupled receptor kinase 6 ISO associated with Parkinson Disease RGD PMID:20410529 RGD:5684919 NCBI chr23:79,437,056...79,454,213
Ensembl chr23:79,437,078...79,453,113
JBrowse link
G GSK3B glycogen synthase kinase 3 beta treatment ISO associated with Parkinsonian Disorders RGD PMID:26997328 RGD:13792768 NCBI chr22:60,732,449...61,002,735
Ensembl chr22:60,733,465...60,997,239
JBrowse link
G HOMER1 homer scaffold protein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:24126708 NCBI chr 4:73,591,105...73,729,680
Ensembl chr 4:73,589,495...73,728,353
JBrowse link
G HTR1A 5-hydroxytryptamine receptor 1A ISO RGD PMID:21352823 RGD:5683628 NCBI chr 4:60,159,542...60,162,947
Ensembl chr 4:60,159,944...60,161,212
JBrowse link
G MAPT microtubule associated protein tau treatment ISO associated with Parkinsonian Disorders RGD PMID:25511986 RGD:13800920 NCBI chr16:59,894,400...60,020,723
Ensembl chr16:59,890,221...59,955,612
JBrowse link
G MTOR mechanistic target of rapamycin kinase treatment ISO associated with Parkinsonian Disorders RGD PMID:23938307 RGD:10040953 NCBI chr20:120,522,667...120,678,988
Ensembl chr20:120,525,737...120,679,020
JBrowse link
G PDYN prodynorphin treatment
severity
ISO CTD Direct Evidence: marker/mechanism
associated with Parkinsonism
associated with Parkinsonism;protein:increased expression:striatum
CTD
RGD
PMID:9767399 PMID:10869049 PMID:17884291 PMID:21737418 RGD:401850563 RGD:401851046 RGD:401900134 NCBI chr 2:54,535,516...54,551,085
Ensembl chr 2:54,535,240...54,551,104
JBrowse link
G PENK proenkephalin treatment
disease_progression
ISO mRNA:increased expression:brain:striatum:
associated with Parkinsonism
associated with Parkinsonism;mRNA:increased expression:striatum
CTD Direct Evidence: marker/mechanism
RGD
CTD
PMID:9767399 PMID:10869049 PMID:20456008 PMID:26113400 RGD:10003039 RGD:401851054 RGD:401900134 NCBI chr 8:52,458,113...52,463,933
Ensembl chr 8:52,457,904...52,463,859
JBrowse link
G PPP1R1B protein phosphatase 1 regulatory inhibitor subunit 1B treatment ISO associated with Parkinsonian Disorders RGD PMID:27771532 RGD:13514053 NCBI chr16:66,530,640...66,541,025
Ensembl chr16:66,530,488...66,541,242
JBrowse link
G RASGRF1 Ras protein specific guanine nucleotide releasing factor 1 ISO CTD Direct Evidence: therapeutic CTD PMID:21115823 NCBI chr26:4,298,091...4,431,606
Ensembl chr26:4,299,116...4,432,420
JBrowse link
G RELA RELA proto-oncogene, NF-kB subunit ISO protein:increased expression:nucleus, brain RGD PMID:18590723 RGD:2298778 NCBI chr 1:8,576,059...8,585,561
Ensembl chr 1:8,576,542...8,586,516
JBrowse link
G RGS4 regulator of G protein signaling 4 treatment ISO associated with Parkinsonian Disorders RGD PMID:24969021 RGD:13524515 NCBI chr25:65,729,344...65,735,278
Ensembl chr25:65,726,394...65,735,381
JBrowse link
G RGS9 regulator of G protein signaling 9 ISO CTD Direct Evidence: marker/mechanism|therapeutic CTD PMID:18160641 PMID:24663062 NCBI chr16:56,199,051...56,291,002
Ensembl chr16:56,199,343...56,288,290
JBrowse link
G TH tyrosine hydroxylase ISO CTD Direct Evidence: therapeutic CTD PMID:15659429 NCBI chr 1:1,969,194...1,977,263
Ensembl chr 1:1,966,460...1,977,218
JBrowse link
Drug-Induced Enteropathy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NOS3 nitric oxide synthase 3 treatment ISO RGD PMID:29064425 RGD:13450913 NCBI chr21:119,174,829...119,196,840 JBrowse link
drug-induced hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ABCC2 ATP binding cassette subfamily C member 2 no_association
susceptibility
ISO DNA:SNPs:multiple:
DNA:polymorphisms,haplotype:promoter:g.-1774delG,g.-1549G>A(human)
RGD PMID:17502832 PMID:22178260 RGD:14700816 RGD:14700817 NCBI chr 9:92,826,423...92,902,389
Ensembl chr 9:92,841,818...92,902,265
JBrowse link
G CYP2E1 cytochrome P450 family 2 subfamily E member 1 ISO DNA:hypermethylation:promoter RGD PMID:23619520 RGD:14700910 NCBI chr26:53,390,054...53,403,309
Ensembl chr26:53,390,089...53,404,211
JBrowse link
G HMGCR 3-hydroxy-3-methylglutaryl-CoA reductase ISO RGD PMID:16140414 RGD:2316848 NCBI chr 4:69,664,784...69,690,343
Ensembl chr 4:69,665,417...69,688,686
JBrowse link
G LPAR1 lysophosphatidic acid receptor 1 ISO protein:increased expression:liver (mouse) RGD PMID:12201952 RGD:10054288 NCBI chr12:28,502,717...28,669,581
Ensembl chr12:28,503,354...28,669,795
JBrowse link
Efavirenz, Poor Metabolism of term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 ISO ClinVar Annotator: match by term: Efavirenz, poor metabolism of ClinVar
OMIM
PMID:15194512 PMID:15622315 PMID:15668854 PMID:15825040 PMID:15864119 More... NCBI chr 6:35,392,699...35,418,171
Ensembl chr 6:35,393,342...35,418,106
JBrowse link
erythema nodosum term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G C3 complement C3 ISO associated with Leprosy RGD PMID:2783924 RGD:7421527 NCBI chr 6:6,250,422...6,289,264 JBrowse link
G CFB complement factor B ISO associated with Leprosy RGD PMID:2783924 RGD:7421527 Ensembl chr17:40,069,909...40,094,207 JBrowse link
G LOC103224275 glutathione S-transferase Mu 1 susceptibility ISO associated with Behcet Syndrome;DNA:deletion:: (human) RGD PMID:22766250 RGD:7794848 NCBI chr20:23,854,969...23,861,634 JBrowse link
G LTA lymphotoxin alpha ISO associated with Sarcoidosis;DNA:polymorphism:intron RGD PMID:19225544 RGD:8548773
G TNF tumor necrosis factor susceptibility ISO associated with Inflammatory Bowel Diseases;DNA:polymorphisms: :-1031T>C(human) RGD PMID:12198697 RGD:7364926
G VDR vitamin D receptor susceptibility ISO associated with Behcet Syndrome;DNA:polymorphism: : rs7975232(human) RGD PMID:24880677 RGD:13217417 NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
JBrowse link
Halothane Hepatitis term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G GPT glutamic--pyruvic transaminase treatment ISO RGD PMID:28921207 RGD:14975164 NCBI chr 8:138,716,802...138,721,421
Ensembl chr 8:138,718,767...138,721,251
JBrowse link
Hand-Foot Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G KDR kinase insert domain receptor treatment ISO DNA:polymorphism:cds:p.H472Q(human) RGD PMID:20630084 RGD:8552374 NCBI chr 7:13,435,059...13,482,236
Ensembl chr 7:13,435,096...13,482,771
JBrowse link
Metabolic Side Effects of Drugs and Substances term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A1 cytochrome P450 family 1 subfamily A member 1 ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr26:8,753,236...8,759,378
Ensembl chr26:8,753,327...8,759,384
JBrowse link
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 treatment ISO associated with nitrate tolerance
Associated with incense smoke exposure;mRNA:increased expression:heart (rat)
associated with nitrate tolerance; protein:decreased expression:thoracic aorta (rat)
RGD PMID:12688525 PMID:16520233 PMID:25687613 RGD:401900296 RGD:401900656 RGD:401900684 NCBI chr26:8,727,996...8,733,254 JBrowse link
G CYP2B6 cytochrome P450 family 2 subfamily B member 6 susceptibility ISO DNA:SNP: :CYP2B6*6 (516G>T,785A>G) ((human) RGD PMID:27289271 RGD:401901173 NCBI chr 6:35,392,699...35,418,171
Ensembl chr 6:35,393,342...35,418,106
JBrowse link
G LOC103231480 myosin-7 ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr29:23,783,610...23,804,981
Ensembl chr29:23,783,557...23,799,771
JBrowse link
G NPPA natriuretic peptide A ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr20:119,942,412...119,946,211
Ensembl chr20:119,944,532...119,945,917
JBrowse link
G NPPB natriuretic peptide B ISO Associated with incense smoke exposure;mRNA:increased expression:heart (rat) RGD PMID:25687613 RGD:401900684 NCBI chr20:119,930,931...119,933,391
Ensembl chr20:119,932,021...119,933,197
JBrowse link
Nakajo Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G PSMB8 proteasome 20S subunit beta 8 ISO ClinVar Annotator: match by term: Nodular erythema digital changes ClinVar PMID:20159315 PMID:20534754 PMID:21129723 PMID:21953331 PMID:25741868 More... NCBI chr17:39,260,774...39,264,990
Ensembl chr17:39,260,511...39,265,166
JBrowse link
nephrotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CACNA1G calcium voltage-gated channel subunit alpha1 G treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr16:42,710,640...42,776,736
Ensembl chr16:42,708,638...42,768,843
JBrowse link
G CACNA1S calcium voltage-gated channel subunit alpha1 S treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr25:28,288,483...28,363,231
Ensembl chr25:28,289,342...28,363,327
JBrowse link
G CAMK2A calcium/calmodulin dependent protein kinase II alpha treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr23:52,829,438...52,899,428
Ensembl chr23:52,829,350...52,899,375
JBrowse link
G CYP24A1 cytochrome P450 family 24 subfamily A member 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 2:9,868,794...9,889,510
Ensembl chr 2:9,868,678...9,885,884
JBrowse link
G CYP27B1 cytochrome P450 family 27 subfamily B member 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr11:53,675,704...53,681,372
Ensembl chr11:53,675,226...53,680,443
JBrowse link
G GATM glycine amidinotransferase ISO RGD PMID:15462098 PMID:19664912 RGD:329961309 RGD:329961312 NCBI chr26:37,836,207...37,853,811
Ensembl chr26:37,836,335...37,852,822
JBrowse link
G GC GC vitamin D binding protein treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 7:20,254,604...20,298,384
Ensembl chr 7:20,253,879...20,298,265
JBrowse link
G GPX3 glutathione peroxidase 3 treatment ISO RGD PMID:22115772 PMID:23662110 PMID:27412471 RGD:401827919 RGD:401827924 RGD:401827925 NCBI chr23:53,576,950...53,585,321 JBrowse link
G HAVCR1 hepatitis A virus cellular receptor 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr23:59,422,769...59,454,183
Ensembl chr23:59,423,334...59,453,531
JBrowse link
G ITPR1 inositol 1,4,5-trisphosphate receptor type 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr22:40,574,569...40,925,857
Ensembl chr22:40,574,374...40,926,842
JBrowse link
G NOS2 nitric oxide synthase 2 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
JBrowse link
G RYR1 ryanodine receptor 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 6:33,080,443...33,234,478
Ensembl chr 6:33,080,758...33,213,788
JBrowse link
G S100A1 S100 calcium binding protein A1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr20:10,172,916...10,176,905 JBrowse link
G S100B S100 calcium binding protein B treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 2:90,188,820...90,194,986
Ensembl chr 2:90,188,639...90,195,023
JBrowse link
G TGFB1 transforming growth factor beta 1 treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr 6:35,651,583...35,674,387
Ensembl chr 6:35,648,677...35,674,365
JBrowse link
G VDR vitamin D receptor treatment ISO RGD PMID:37244046 RGD:329853759 NCBI chr11:44,062,198...44,126,295
Ensembl chr11:44,065,457...44,166,684
JBrowse link
neurotoxicity term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G MBP myelin basic protein treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr18:2,844,154...2,996,640
Ensembl chr18:2,868,795...2,997,046
JBrowse link
G MOG myelin oligodendrocyte glycoprotein treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr17:42,947,174...42,963,046
Ensembl chr17:42,947,279...42,962,159
JBrowse link
G MYRF myelin regulatory factor treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr 1:12,066,277...12,103,091 JBrowse link
G PLP1 proteolipid protein 1 treatment ISO RGD PMID:33166664 RGD:213230154 NCBI chr  X:91,671,535...91,687,693
Ensembl chr  X:91,671,878...91,687,878
JBrowse link
NSAID-Enteropathy term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CASP9 caspase 9 ISO RGD PMID:25014874 RGD:13782349 NCBI chr20:116,772,819...116,798,402
Ensembl chr20:116,772,155...116,798,930
JBrowse link
G PTGER3 prostaglandin E receptor 3 treatment ISO RGD PMID:11991626 RGD:10003093 NCBI chr20:62,093,830...62,293,360
Ensembl chr20:62,095,458...62,174,959
JBrowse link
G PTGER4 prostaglandin E receptor 4 treatment ISO RGD PMID:11991626 RGD:10003093 NCBI chr 4:39,440,697...39,453,983
Ensembl chr 4:39,440,276...39,454,004
JBrowse link
Poor Metabolism of Thiopurines, 1 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TPMT thiopurine S-methyltransferase ISO ClinVar Annotator: match by term: THIOPURINES, POOR METABOLISM OF, 1 OMIM
ClinVar
PMID:8561894 PMID:9931345 PMID:25741868 NCBI chr17:53,987,561...54,012,647
Ensembl chr17:53,987,559...54,014,650
JBrowse link
Poor Metabolism of Thiopurines, 2 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G NUDT15 nudix hydrolase 15 ISO ClinVar Annotator: match by term: Thiopurines, poor metabolism of, 2 OMIM
ClinVar
PMID:22992668 PMID:25108385 PMID:25624441 PMID:25741868 PMID:26033531 More... NCBI chr 3:25,966,148...25,974,143
Ensembl chr 3:25,966,876...25,973,647
JBrowse link
Serotonin Syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CABP1 calcium binding protein 1 ISO protein:altered expression:postsynaptic density RGD PMID:19224364 RGD:14399959 NCBI chr11:115,934,747...116,021,645 JBrowse link
Serum Sickness term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALB albumin ISO CTD Direct Evidence: marker/mechanism CTD PMID:350256 PMID:9380243 NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
JBrowse link
Stevens-Johnson syndrome term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALB albumin ISO CTD Direct Evidence: therapeutic CTD PMID:12239465 NCBI chr 7:21,872,036...21,890,095
Ensembl chr 7:21,876,132...21,891,407
JBrowse link
G APCS amyloid P component, serum ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:4,360,955...4,363,810
Ensembl chr20:4,358,654...4,362,095
JBrowse link
G C1QA complement C1q A chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:110,024,847...110,027,868 JBrowse link
G C1QC complement C1q C chain ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:110,016,355...110,021,123
Ensembl chr20:110,016,362...110,020,854
JBrowse link
G CAV1 caveolin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr21:85,222,724...85,258,562
Ensembl chr21:85,222,879...85,258,627
JBrowse link
G CELF2 CUGBP Elav-like family member 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 9:10,534,623...11,395,516
Ensembl chr 9:11,080,404...11,388,136
JBrowse link
G CLU clusterin ISO mRNA:decreased expression:conjunctiva RGD PMID:12036968 RGD:8699507 NCBI chr 8:25,704,441...25,721,789
Ensembl chr 8:25,703,257...25,721,789
JBrowse link
G COPS5 COP9 signalosome subunit 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 8:62,905,924...62,925,205
Ensembl chr 8:62,905,906...62,925,201
JBrowse link
G CRP C-reactive protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr20:4,232,262...4,235,826
Ensembl chr20:4,232,913...4,235,377
JBrowse link
G CSF3 colony stimulating factor 3 ISO CTD Direct Evidence: therapeutic CTD PMID:11321886 NCBI chr16:66,162,814...66,166,192
Ensembl chr16:66,163,681...66,165,172
JBrowse link
G CTNNB1 catenin beta 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr22:2,679,488...2,725,034
Ensembl chr22:2,684,022...2,723,949
JBrowse link
G CUL1 cullin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr21:117,271,477...117,373,983
Ensembl chr21:117,271,548...117,374,379
JBrowse link
G CUL4A cullin 4A ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 3:91,211,238...91,267,236
Ensembl chr 3:91,212,193...91,268,838
JBrowse link
G DERL1 derlin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 8:117,587,373...117,617,233
Ensembl chr 8:117,586,496...117,617,194
JBrowse link
G ELMO1 engulfment and cell motility 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr21:21,066,910...21,639,149
Ensembl chr21:21,066,924...21,640,705
JBrowse link
G EP300 E1A binding protein p300 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr19:23,634,132...23,726,095
Ensembl chr19:23,634,571...23,724,979
JBrowse link
G FBXO6 F-box protein 6 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr20:120,116,125...120,127,025
Ensembl chr20:120,116,169...120,126,920
JBrowse link
G IFNA2 interferon alpha 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr12:58,468,018...58,469,825 JBrowse link
G IFNG interferon gamma ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr11:63,785,493...63,791,071
Ensembl chr11:63,786,041...63,790,473
JBrowse link
G LBP lipopolysaccharide binding protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 2:25,375,364...25,407,181
Ensembl chr 2:25,374,755...25,406,839
JBrowse link
G LOC103218970 alpha-1-acid glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr12:25,257,002...25,261,255
Ensembl chr12:25,256,969...25,260,446
JBrowse link
G LOC103224275 glutathione S-transferase Mu 1 ISO RGD PMID:28689274 RGD:14700974 NCBI chr20:23,854,969...23,861,634 JBrowse link
G LOC103231897 properdin ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr  X:44,801,388...44,807,177
Ensembl chr  X:44,801,354...44,807,402
JBrowse link
G LRG1 leucine rich alpha-2-glycoprotein 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr 6:4,272,231...4,275,060
Ensembl chr 6:4,272,214...4,274,460
JBrowse link
G MIF macrophage migration inhibitory factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:9372356 NCBI chr19:7,000,837...7,001,700
Ensembl chr19:7,000,793...7,001,757
JBrowse link
G NEDD4 NEDD4 E3 ubiquitin protein ligase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr26:27,487,652...27,655,742
Ensembl chr26:27,487,796...27,655,992
JBrowse link
G NFKBIZ NFKB inhibitor zeta ISO MouseDO NCBI chr22:79,044,624...79,077,736
Ensembl chr22:79,044,619...79,055,776
JBrowse link
G NOS2 nitric oxide synthase 2 ISO CTD Direct Evidence: marker/mechanism CTD PMID:10620138 NCBI chr16:21,533,011...21,576,645
Ensembl chr16:21,533,484...21,574,257
JBrowse link
G NUCB1 nucleobindin 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 6:42,133,505...42,154,461 JBrowse link
G PARP1 poly(ADP-ribose) polymerase 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr25:3,350,798...3,405,040 JBrowse link
G PML PML nuclear body scaffold ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr26:9,441,998...9,494,949
Ensembl chr26:9,451,112...9,494,931
JBrowse link
G PROS1 protein S ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr22:86,728,089...86,840,413
Ensembl chr22:86,728,339...86,840,356
JBrowse link
G PSMC5 proteasome 26S subunit, ATPase 5 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr16:57,457,670...57,462,321
Ensembl chr16:57,457,720...57,462,249
JBrowse link
G PTGER3 prostaglandin E receptor 3 ISO CTD Direct Evidence: marker/mechanism CTD PMID:21966456 NCBI chr20:62,093,830...62,293,360
Ensembl chr20:62,095,458...62,174,959
JBrowse link
G PTGIS prostaglandin I2 synthase ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 2:14,420,318...14,484,667
Ensembl chr 2:14,441,983...14,488,264
JBrowse link
G RB1 RB transcriptional corepressor 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr 3:26,220,783...26,393,671
Ensembl chr 3:26,220,803...26,394,546
JBrowse link
G RBX1 ring-box 1 ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr19:23,500,361...23,521,676
Ensembl chr19:23,500,356...23,522,723
JBrowse link
G TNF tumor necrosis factor ISO protein:increased expression:blister: RGD PMID:9852250 RGD:7401184
G VCP valosin containing protein ISO CTD Direct Evidence: marker/mechanism CTD PMID:25811541 NCBI chr12:45,545,139...45,560,702
Ensembl chr12:45,545,507...45,563,380
JBrowse link
G VWF von Willebrand factor ISO CTD Direct Evidence: marker/mechanism CTD PMID:34142820 NCBI chr11:5,994,499...6,176,949
Ensembl chr11:5,994,039...6,162,260
JBrowse link
Tardive Dyskinesia term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP1A2 cytochrome P450 family 1 subfamily A member 2 treatment ISO associated with schizophrenia RGD PMID:10889552 RGD:1358545 NCBI chr26:8,727,996...8,733,254 JBrowse link
G DRD3 dopamine receptor D3 ISO associated with schizophrenia RGD PMID:12960753 RGD:1581250 NCBI chr22:66,683,987...66,737,645
Ensembl chr22:66,691,177...66,736,690
JBrowse link
G SOD2 superoxide dismutase 2 ISO associated with schizophrenia RGD PMID:12960753 RGD:1581250 NCBI chr13:87,284,537...87,297,998
Ensembl chr13:87,280,686...87,297,974
JBrowse link
thiopurine S-methyltransferase deficiency term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G TPMT thiopurine S-methyltransferase ISO ClinVar Annotator: match by term: Thiopurine methyltransferase deficiency ClinVar PMID:1960624 PMID:7862671 PMID:8561894 PMID:8644731 PMID:9177237 More... NCBI chr17:53,987,561...54,012,647
Ensembl chr17:53,987,559...54,014,650
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  disease 17472
    Chemically-Induced Disorders 1160
      Drug-Related Side Effects and Adverse Reactions 549
        Anticholinergic Syndrome 0
        Cardiotoxicity + 30
        Chemical and Drug Induced Liver Injury + 347
        Chemotherapy-Related Cognitive Impairment 0
        Chemotherapy-induced nausea and vomiting 0
        Chloramphenicol Toxicity 0
        Drug-Induced Akathisia 0
        Drug-Induced Dyskinesia + 33